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Abstract
Annotation Tools for Multivariate Gene Set Testing of Non-Model Organisms
by
Russell K Banks, Master of Science
Utah State University, 2015

Major Professor: Dr. John R. Stevens
Department: Mathematics and Statistics
Many researchers across a wide range of disciplines have turned to gene expression analysis to aid in predicting and understanding biological outcomes and mechanisms. Because
genes are known to work in a dependent manner, it’s common for researchers to first group
genes in biologically meaningful sets and then test each gene set for differential expression.
Comparisons are made across different treatment/condition groups.
The meta-analytic method for testing differential activity of gene sets, termed multivariate gene set testing (mvGST), will be used to provide context for two persistent and
problematic issues in gene set testing. These are: 1) gathering organism specific annotation
for non-model organisms and 2) handling gene annotation ambiguities.
The primary purpose of this thesis is to explore different gene annotation gathering
methods in the building of gene set lists and to address the problem of gene annotation ambiguity. Using an example study, three different annotation gathering methods are proposed
to construct GO gene set lists. These lists are directly compared, as are the subsequent
results from mvGST analysis. In a separate study, an optimization algorithm is proposed
as a solution for handling gene annotation ambiguities.
(93 pages)
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Public Abstract
Annotation Tools for Multivariate Gene Set Testing of Non-Model Organisms
by
Russell K Banks, Master of Science
Utah State University, 2015

Major Professor: Dr. John R. Stevens
Department: Mathematics and Statistics
Microarray chip technology enables researchers to obtain measures of gene activity for
essentially all genes in an organism. After grouping genes into biologically meaningful sets,
researchers employ certain statistical tests to identify which gene sets (biological processes)
show different levels of activity across different treatment groups. The idea is to identify
which biological processes are significantly affected by a certain treatment/condition in a
given organism.
Non-model organisms (such as sheep) are not widely studied so gene set membership
information is not always readily accessible. This thesis work utilizes two microarray studies
involving sheep to provide researchers with working examples of three different methods for
gathering gene set membership information for genes in non-model organisms.
Often after gathering gene set membership information for non-model organisms, there
exits ambiguity as to which set each gene belongs. A procedure for working through these
ambiguities is presented. All R code used to produce the presented results is included as
an appendix.
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Chapter 1
Background
1.1

Introduction
The abundance of experimental gene expression measurements and annotation infor-

mation has provided both opportunities and challenges for the bio-statistical community.
Many sophisticated statistical methods for the analysis of high-throughput gene expression
data have been developed and refined. Unsatisfyingly, different methods still tend to identify different gene sets as significantly differentially expressed with no consensus as to which
method is preferable. Some of the more popular methods include GSEA, GSA, Global
Ancova, SAFE, and Global testing [1]. For the purposes of this thesis, the meta-analytic
method for testing differential activity of gene sets, termed multivariate gene set testing
(mvGST), will be used to provide context for two persistent and problematic issues in gene
set testing. These are: 1) gathering organism-specific annotation for non-model organisms
and 2) handling gene annotation ambiguities.
The primary purpose of this thesis is to explore different gene annotation gathering
methods in the building of gene set lists and to address the problem of gene annotation ambiguity. Using an example study, three different annotation gathering methods are proposed
to construct GO gene set lists. These lists are directly compared, as are the subsequent
results from mvGST analysis. In a separate study, an algorithmic approach borrowed from
the field of graph theory is proposed as a solution for handling gene annotation ambiguities.
Chapter 1 of this thesis introduces previously-presented ideas and issues that are used
in subsequent chapters.

1.2

Gene Expression and Gene Expression Technology
Current methods for measuring gene expression are based on the concept that DNA
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codes for RNA which in turn has a molecular function within the organism or codes for
polypeptides (the building blocks for proteins) [2]. In either case, the functional workings
of an organism can be profiled by measures of RNA abundance and in theory is also a
measure of RNA activity or gene expression activity. While it’s true that every cell in an
organism contains the entire genetic material specific to that organism, not every cell’s DNA
is expressed identically. For example, the same segment of DNA that codes for identical
gene products might be active in one cell type while simultaneously being completely inert
in another.
Different high-throughput technologies allow essentially all genes in the genome to be
measured experimentally. These large scale experimental gene expression profiles can be
obtained for thousands of genes simultaneously [3]. Generally, different gene expression
measurement technologies can be classified as array-based (microarrays) or sequence-based
(next-generation sequencing). There are advantages and disadvantages to both types, but
such discrepancies are not immediately relevant to the purposes of this thesis. The example
studies chosen for this thesis are array-based gene expression studies [4] [5].

1.2.1

Microarray Technology

The following is a physical description of a microarray. These concepts are important
in considering methods to measure annotation strength, see Chapter 3.2.3.
A DNA microarray is an orderly arrangement of thousands of identified sequenced genes printed on an impermeable solid support, usually glass, silicon
chips or nylon membrane. Each attached and identified sequenced gene corresponds to a fragment of genomic DNA, cDNAs, PCR products or chemically
synthesized oligonucleotides of up to 70mers and represents a single gene. Usually a single DNA microarray slide/chip may contain thousands of spots with
each spot representing a single gene and collectively the entire genome of an
organism [6].
These spots are annotated with specific labels called probe identifiers, or probeIDs.
Each probeID in theory should be annotated to one gene identifier, or geneID. When
probeIDs and geneIDs are not in a one-to-one relationship, these annotations can be called
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ambiguous annotations. Microarray manufacturers often provide probeID-to-geneID annotation. An example of manufacturer mappings is given in [5], the use of which is detailed in
Chapters 3.1.3 and 3.2.1. The probe sequences of the Agilent-019921 microarray are 60-mer
sequences.

1.3

Preprocessing Overview
A lengthy discussion of statistical preprocessing methodology need not be discussed

here. It is sufficient to understand the purpose and data structure resulting from such
methods. An excellent review of the topic can be found in Zhijin Wu’s paper [7].
Preprocessing of oligonucleotide arrays typically include image processing, background
adjustment, data normalization/transformation and sometimes summarization when multiple probes are used to target one genomic unit [7].
The original hybridization data obtained from a microarray chip is an image. Through
image processing, pixels are measured resulting in raw intensity values for each probe. Background adjustment methods remove local artifacts and “noise.” Normalization methods are
meant to transform the data in such a way as to make measurements from different arrays
comparable in statistical analyses. Summarization methods combine probe intensity levels
resulting in one gene expression level value for every probe or probe set identifier [7] [8].
While many different methods of preprocessing exist, they mostly differ in the details
of how they accomplish the largely universal steps described above [7] [8]. It has also been
shown that preprocessing methods can significantly impact subsequent statistical analyses
[9]. RMA preprocessing (Robust Multi-Array Average) was the preprocessing method of
choice in both example studies considered in this thesis [4] [5].

1.3.1

Expression Set Matrix

The results of RMA preprocessing of raw data can be summarized in an expression
set matrix. The values of an expression set matrix are considered gene expression level
data and are typically on the log2 scale. Rows are specified with probeIDs and columns
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specify array sample identity. An expression set matrix can be used in statistical tests of
significance meant to identify differentially expressed genes.
A header of the resulting data structure after RMA preprocessing of the raw data for
example study 1 is shown in table 1.4. This data was obtained through the Gene Expression
Omnibus repository archived under accession number GSE47776 [4].

Table 1.1: Partial Expression Set Matrix

AFFX-BioB-3 at
AFFX-BioB-5 at
AFFX-BioB-M at
AFFX-BioC-3 at
AFFX-BioC-5 at
AFFX-BioDn-3 at
AFFX-BioDn-5 at
AFFX-Bt-A00196-1 s at

GSM1159567

GSM1159568

GSM1159569

GSM1159570

7.486
7.393
7.977
9.206
8.570
11.263
9.985
3.743

7.565
7.365
7.958
9.225
8.634
11.363
10.142
3.526

7.575
7.277
7.953
9.169
8.537
11.309
9.970
3.839

7.658
7.357
7.990
9.194
8.573
11.295
10.025
4.015

Note: Full dimensions are 24128 rows by 12 columns. Data are RMA processed values from Study 1 2.1. Rows contain probeIDs of
Affymetrix Bovine Microarray. Columns contain sample identifiers.

1.4

Statistical Tests for Differential Expression of Genes
There are various approaches to test for differential expression (hereafter, DE) among

genes across conditions of interest for microarray experiments. Many papers compare different methods, but a general consensus as to the best has not been reached. The development
of new methods is an active area of research [10] [11]. Generally, “One may distinguish between parametric tests. . . and non-parametric tests. One or two group t-test comparisons,
multiple group ANOVA, and more general trend tests are all instances of linear models
that are frequently used for assessing differential gene expression” [12]. Specific tests commonly used in identification of DE genes in microarray analyses include SAM (Significance
Analysis of Microarrays) and Limma (Linear Models for Microarray Data) [13] [14]. Both
are readily accessible in the Bioconductor project in R [15] [16]. The Limma approach was
selected for the identification of DE genes in both example studies described in Chapters
2.1 and 2.2.
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1.4.1

Limma/eBayes

There are a multitude of methods to test for DE among genes in microarray analysis.
One commonly used method is Linear Models for Microarray Data (Limma).
Limma is a package for differential expression analysis of data arising from microarray experiments. The package is designed to analyze complex experiments
involving comparisons between many RNA targets simultaneously... The central
idea is to fit a linear model to the expression data for each gene. Empirical Bayes
and other shrinkage methods are used to borrow information across genes making the analyses stable even for experiments with small number of arrays [14].
Limma is flexible with respect to platform and experimental design. While use of
Limma in this thesis is restricted to microarray data, the methods can be implemented for
count data (RNA-Seq data for example) as if they were microarray data by way of a voom
transformation as described by Charity Law et al. [17]. Multiple contrasts of interest can
be tested by the Limma method. These contrasts are constructed to address researchers’
hypotheses (tested contrasts for the example studies can be found in Chapters 2.1 and 2.2).
The Limma package also provides options to account for multiple tests of DE among
genes. Genome-wide microarray experiments typically have thousands of probe sets representing genes, so it becomes necessary to adjust for the high number of tests to control
error rates. One common method to control the false discovery rate is by comparing the
Benjamini-Hochberg adjusted p-values to some rejection threshold α instead of raw p-values.
Table 1.2 provides an example of output from a Limma procedure on the first contrast of
example Study 1.
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Table 1.2: Limma/eBayes Results with Bejamini-Hochberg Adjusted P-values

AFFX-BioB-3 at
AFFX-BioB-5 at
AFFX-BioB-M at
AFFX-BioC-3 at
AFFX-BioC-5 at
AFFX-BioDn-3 at

Day12.P-Day12.NP

AveExpr

F

P.Value

adj.P.Val

−0.025
0.071
0.061
0.077
0.028
0.026

7.744
7.456
8.150
9.351
8.722
11.433

0.034
0.479
0.228
0.491
0.069
0.059

0.857
0.502
0.641
0.496
0.797
0.811

0.984
0.927
0.958
0.926
0.979
0.981

Note: Only the first 6 rows of 24128 are shown. For more detail about the contrasts considered in Example Study 1 see Chapter 2.1.
Rows contain probeIDs of Affymetrix Bovine Microarray. Columns contain sample identifiers.

1.4.2

Matrix of P-Values

Often researchers are interested in multiple contrasts of interest simultaneously. To
test the multiple contrasts of interest for both example studies, implementation of the R
package mvGST will be used. This method is described in more detail in Chapter 1.5.2.
Chapter 1.4.1 briefly describes the Limma procedure for obtaining p-values for genes
in a single contrast of interest. If the p-value for a given gene is lower than some rejection
threshold α we say that that gene is differentially expressed for the corresponding contrast
(e.g. these genes are differentially expressed in Treatment A vs. Control). Results for
tests of differential expression among genes under multiple contrasts of interested are easily
summarized in a matrix of p-values, where columns indicate the contrasts tested and the
rows specify probe or gene identifiers. Table 1.3 is a header of the p-value matrix obtained
in example Study 1.
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Table 1.3: P-Value Matrix Header

AFFX-BioB-3 at
AFFX-BioB-5 at
AFFX-BioB-M at
AFFX-BioC-3 at
AFFX-BioC-5 at
AFFX-BioDn-3 at

Day12.P-Day12.NP

Day14.P-Day14.NP

0.857
0.502
0.641
0.496
0.797
0.811

0.661
0.527
0.576
0.786
0.621
0.846

Note: P-values result from DE testing methods described in Chapter 1.4.1.
The full matrix contains 24128 rows.

1.5

Statistical Tests for Differential Expression of Gene Sets
Functional aspects of an organism can include gene products from numerous genes. The

identification of DE genes across treatments alone proves to be inadequate for researchers
concerned with deriving large-scale biological meaning due to treatment effect.
Statistical methods that test whether a gene set is differentially expressed (or differentially active) across treatment groups can yield insights into large-scale biological functions
if the gene sets are constructed in biologically meaningful ways. “The study of gene set
function most commonly makes use of controlled vocabulary in the form of ontology annotations” [18]. One widely used public repository where such ontology annotations can be
found is provided by the Gene Ontology Consortium [19]. More about the GO Consortium
is found in Chapter 1.5.1. GO annotations are the only gene-set annotations considered in
this thesis for reasons discussed in Chapter 1.5.2. Exploring different methods for collecting
GO annotations to build GO gene set lists is one of the primary purposes of this thesis and
is demonstrated in Chapter 3.
As was the case with tests for DE among genes, there are many and varied statistical
methods for testing DE among gene sets. Some of the most popular methods have been
stated previously in the introduction, Chapter 1.1. The multivariate gene set testing method
(mvGST) has been selected to analyze DE among different GO gene set lists, see Chapter
1.5.2 for more information on mvGST.
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1.5.1

The GO Consortium

An introduction to the GO Consortium’s purpose and contributing member databases
can be found on the organization’s web page. It is sufficient here to state, “[t]he Gene
Ontology Consortium (GOC) is a set of model organism and protein databases and biological
research communities actively involved in the development and application of the Gene
Ontology” [19]. Prior to the GO consortium, it was all but impossible to compare functional
gene category profiles across different organisms because different organisms were annotated
using different conventions [3].
The GO is comprised of a collection of GO terms each of which has a unique identifier
(GO ID). Each GO ID can be thought of as a list of genes where each gene has a geneID, or
probeID if the microarray is directly annotated to GO. Each gene annotated to a GO term
only contributes to the gene product attribute identified by the GO term. It’s important
to note, mvGST analysis is only appropriate for gene set lists where elements of each gene
set are contributing members only.
Additionally, the GO can be thought of as a collection of three separate ontologies or
domains for gene product properties. A short description of each is included below [19].
Cellular Component (CC): These terms describe a component of a cell that is part of
a larger object, such as an anatomical structure or a gene product group.
Molecular Function (MF): Molecular function terms describe activities that occur at
the molecular level, such as “catalytic activity” or “binding activity.” GO molecular
function terms represent activities rather than the entities (molecules or complexes)
that perform the actions, and do not specify where, when, or in what context the
action takes place. Molecular functions generally correspond to activities that can be
performed by individual gene products, but some activities are performed by assembled
complexes of gene products.
Biological Process (BP): A biological process term describes a series of events accomplished by one or more organized assemblies of molecular functions. The general rule
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to assist in distinguishing between a biological process and a molecular function is that
a process must have more than one distinct step.
“A GO annotation consists of a GO term associated with a specific reference that describes the work or analysis upon which the association between a specific GO term and gene
product is based. Each annotation also must include an evidence code to indicate how the
annotation to a particular term is supported” [19]. These evidence codes are generally separated by two types: Experimental Evidence codes and Computational Analysis Evidence
codes. For more information about evidence codes, one should access the GO Consortium’s
web page under “guide to GO evidence codes.” They are not used in the annotation gathering methods contained in this thesis, but may provide additional information to measure
annotation strength, see Chapter 4.3.

1.5.2

Multivariate Gene-Set Testing

The following is taken from the mvGST package help file in R and provides an introduction to the package.
mvGST provides platform-independent tools to identify GO terms (gene sets)
that are differentially active (up or down) in multiple contrasts of interest. Given
a matrix of one-sided p-values (rows for genes, columns for contrasts), mvGST
uses meta-analytic methods to combine p-values for all genes annotated to each
gene set, and then classify each gene set as being significantly more active (1),
less active (-1), or not significantly differentially active (0) in each contrast of
interest. With multiple contrasts of interest, each gene set is assigned to a profile
(across contrasts) of differential activity. Tools are also provided for visualizing
(in a GO graph) the gene sets classified to a given profile [20].
The testing and profiling of each gene set as more active (1), less active (-1), or not
significantly differentially active (0), is quite efficient and informative. Many methods for
testing gene set enrichment identify only significant differential activity across a single
contrast of interest let alone three levels of significant differential activity across multiple
contrasts. Detailed information about the statistical methodology behind mvGST can be
found in [20]. It is worthy to further emphasize here that the additional levels of differential
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activity identified by mvGST stems from the understanding that every gene annotated to
a GO term contributes to the functional property described by the GO term. Therefore,
one-sided p-values for each gene, obtained by any statistical method for testing DE among
genes, can be used as a measure of contribution to the GO term.
A Benjamani-Yekutieli adjustment [20] for multiple possible dependent comparisons
will be used in mvGST analysis. It would be inappropriate to adjust for multiple comparisons twice, so raw p-values will be used to construct the matrices of p-values used in
mvGST analysis, see Chapter 3.
The package mvGST is not only a tool by which DE analysis for gene sets can be
conducted, it’s also a tool the user can use to gather annotation information and build
GO gene set lists. Annotation gathering methods provided by mvGST currently supports
annotation for 22 species. This limitation is due to the fact that there are only 22 organismspecific annotation packages in Bioconductor.
These packages can contain probeID-to-GO annotation and geneID-to-GO annotation.
Translation options are provided when probeID-to-GO annotations are not available but
geneID-to-GO annotations are. Translation methods provided in mvGST give statistical
solutions to handle gene translation ambiguities, but have the potential to bias subsequent
gene set testing by omitting or creating p-values. This thesis proposes an alternative algorithmic solution for handling translation ambiguities.

1.6

Annotation Sources
An annotation in functional gene expression studies refers to a statement that a gene

product has a particular functional property. These statements are stored in structured semantic databases of which the GO is an example. There are many bio-ontological databases
that describe important aspects of biological domains and are often specific to field of study.
These databases not only store annotation statements but also simplify or omit less important or irrelevant aspects, allowing for specific and meaningful queries [3].
In recent years, access to regularly updated bio-ontological databases has grown both
more important and efficient. The increasing rate of annotation entries to databases by
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biological researchers and the improvements to database user-interfaces have greatly accelerated research endeavors in the field of bioinformatics and has made access to current
annotation vitally important.

1.6.1

Gene Expression Omnibus

The example studies chosen to demonstrate methods proposed in this thesis were obtained through the Gene Expression Omnibus. “[The] GEO is an international public
repository that archives and freely distributes microarray, next-generation sequencing, and
other forms of high-throughput functional genomics data submitted by the research community [21].” GEO records are organized by platform, sample and series.
“A Platform record is composed of a summary description of the array or sequencer
and, for array-based Platforms, a data table defining the array template. Each Platform
record is assigned a unique and stable GEO accession number (GPLxxx). A Platform may
reference many Samples that have been submitted by multiple submitters” [21]. Submitted
platform annotation information can come from the platform manufacturers, the research
group (submitters), or a combination of these. We explore this topic through two specific
examples in Chapter 2.
“A Sample record describes the conditions under which an individual Sample was
handled, the manipulations it underwent, and the abundance measurement of each element
derived from it. Each Sample record is assigned a unique and stable GEO accession number
(GSMxxx). A Sample entity must reference only one Platform and may be included in
multiple Series [21].”
“A Series record links together a group of related Samples and provides a focal point
and description of the whole study. Each Series record is assigned a unique and stable GEO
accession number (GSExxx) [21].” Information in a GSE submission include: summary
of experiment, overall design, contributor(s), submission details and researchers contact
information, platform information, curated data, and raw data. Both Study 1 and Study 2
are GSE records, see Chapter 2.
The Bioconductor package GEOquery provides a user interface to the GEO repository
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from R. To upload information from the GEO repository into R, one need only reference the
targeted experiment’s GSE accession. More on GEOquery can be found in the GEOquery
help file.

1.6.2

Platform Manufacturer’s Annotation

The manufacturers of different gene expression technologies often provide access to
annotation information that maps manufacturer designed genes to common public domain
sequences [22]. For well-annotated microarray chips, direct annotation to GO might be
available. This option is attractive for researchers interested in GO gene set analysis as
mapping from probeIDs to GO-annotated geneIDs is unnecessary, thus avoiding researcher
created mapping ambiguities (annotation ambiguities are discussed in more detail in Chapter 3.
Platform manufacturers’ gene annotation can be accessed through online annotation
repositories (see Chapters 3.1.2 and 3.2.1), annotation packages in R (see Chapter 3.1.1), or
can be downloaded directly from the manufacturer’s website (see Chapters 3.1.3 and 3.2.1).
Annotation information from manufacturers’ websites is stored as individual files for each
array type and is frequently updated, usually quarterly [23] [22]. These files tend to be
quite large, ranging from 5MB to 170 MB.

1.6.3

Ensembl’s BioMart

“Ensembl is a genomic interpretation system providing the most up-to-date annotations, querying tools and access methods for chordates and key model organisms. Ensembl
does not produce genome assemblies, instead [they] provide annotation on genome assemblies that have been deposited into the INSDC (GenBank, ENA, DDBJ) and are publicly
available” [24].
Biomart is considered a “powerful” tool for microarray analysis [25]. The entire repository is easily accessed in R through the R package biomaRt. The annotation found in
biomaRt is commonly used to interpret and map gene identifiers [25]. The current Ensembl
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Release 80 has gene annotation for 69 organisms. This number is far larger than the 30
organism-specific annotation packages currently in R, see Chapter 1.6.4.

Updates and Releases
The Ensembl release cycle is approximately every three months and may occasionally
be longer if considerable development work is being undertaken. Previous releases are
archived as completely separate websites allowing researchers to reproduce analysis results.
The current version as of May 2015 is release 80. Ensembl genes 80 is the version used in
all Biomart queries of this thesis, see Chapter 3.
Previous Biomart releases can be readily accessed using the package biomaRt in R.
The recommended method for accessing previous releases of Biomart is by changing the
host parameter in the useMart function. Table 1.4 shows the currently available Biomart
release archives.

Table 1.4: Available Biomart Release Versions and Dates
Version
Ensemble
Ensemble
Ensemble
Ensemble
Ensemble
Ensemble
Ensemble
Ensemble
Ensemble

Date
80
79
78
77
76
74
73
72
71

May 2015
Mar 2015
Dec 2014
Oct 2014
Aug 2014
Dec 2013
Sep 2013
Jun 2013
Apr 2013

Version
Ensemble
Ensemble
Ensemble
Ensemble
Ensemble
Ensemble

Date
70
69
68
67
59
54

Jan 2013
Oct 2012
Jul 2012
May 2012
Aug 2010
May 2009

Biomart Query Structure
It may be beneficial to visualize an example of a Biomart query. Table 1.5 shows all
Ensembl geneIDs annotated to at least one GO ID for the Ovis aries (sheep) data set in
Study 1, see Chapter 2.2. The table also provides a third column identifying the GO domain
for each geneID-to-GO annotation. Tables such as these were used to build GO gene set
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lists in Chapter 3 It is interesting to note that Ovis aries is not an organism supported by
mvGST annotation methods because there is not an org.db package for Ovis aries within
R.
Table 1.5: Partial Results of a Biomart Query

1
2
3
4
5
6
7
8

1.6.4

ensembl gene id

go id

go domain

ENSOARG00000000006
ENSOARG00000000006
ENSOARG00000000006
ENSOARG00000000006
ENSOARG00000000006
ENSOARG00000000006
ENSOARG00000000006
ENSOARG00000000006

GO:0005739
GO:0005743
GO:0008137
GO:0016020
GO:0016021
GO:0016491
GO:0055114
GO:0070469

cellular component
cellular component
molecular function
cellular component
cellular component
molecular function
biological process
cellular component

Annotation Packages in R

OrganismDbi is a meta framework for annotation packages in R. “The organismDbi
is a software package that helps tie together different annotation resources [26].” These
packages are in effect meant to be the place where “ALL” genetic information about a
specific organism can be found and queried [26]. Consequently, these packages can be very
large. OrgDb packages are updated quarterly. Organism-level packages in R are primarily
based on mapping using Entrez Gene identifiers [26]. As of May 2015, Bioconductor provides
some type of annotation information for only 30 different organisms [27].
Platform-level rather than organism-level packages are assembled packages in R using
microarray platform annotation information. This information provides annotation primarily based on mapping using the platform probeIDs. For a well-annotated platform, packages
that contain direct GO annotations from the GO Consortium might be available.
R tools have been developed to combine information across different annotation packages using the four methods columns, key types, keys and select [26]. If a platform package
exists for a given organism but is not included in the org.db packages, they can be combined
quickly and easily for the construction of gene set lists. This method would be applicable if
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a platform annotation package doesn’t include GO annotation. See Chapter 3.3 as to why
these methods of annotation were not included in this thesis.

1.7

Stable Marriage Problem Algorithm
A stable marriage problem (SMP) algorithm accomplishes the task of finding stable

mappings between elements of two different sets given input about preferences for every
element in both sets [28]. The sets can be thought of as two different columns, men and
women, with the elements of column one being different men and the elements of column
two being different women. A mapping can be thought of as a marriage. What is meant by
stability is that no marriage pairing or mapping will be better for both individuals in any
given pairing. In other words, taking into account individual marriage preferences for both
men and women, a SMP algorithm assures there is no pairing in which both the man and
the woman would be happier. The result is a bijective mapping.
An unequal number of men and women in the two columns do not invalidate the
proof, provided by David Gale and Lloyd Shapley in 1962. Their proof states that a SMP
can always be solved in such a way as all marriages are stable [29]. When columns are
of unequal length, the returned bijective mapping will simply be of length equal to the
smallest column. The following is a somewhat simple example in that only 5 men and 4
women are considered. The example is explained according to the implementation of the
SMP algorithm in the matchingMarkets R package [30].
Given 5 men and 4 women one wants to find the most stable marriages possible accounting for preferences each man and each woman provides. Let the men’s preferences be
expressed as the matrix men.pref s with the ith column containing man i’s ranking over
the women in decreasing order of preference (i.e. most preferred first).

1


4

men.pref s = 

3

2


4 1 3 2


3 2 2 3



2 3 1 4

1 4 4 1
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.
Let the women’s preferences be expressed as the matrix women.pref s with the jth
column containing woman j’s ranking over the men in decreasing order of preference (i.e.
most preferred first).

1


2


women.pref s = 
3


5

4


2 3 5


3 2 4


1 1 3



4 4 2

5 5 1

The resulting matrix stable.marriages (produced using the daa function from the
matchingMarkets [30] package in R) provides the optimal pairings with columns representing
the women and rows representing the men. Each TRUE value represents a marriage. Notice
only one TRUE in each i, j element of the matrix. Row 4 (man 4) has no marriage mapping
(remember there were 5 men and 4 women).


T RU E

F ALSE F ALSE F ALSE







F ALSE F ALSE T RU E F ALSE 





stable.marriages = F ALSE T RU E F ALSE F ALSE 





F ALSE F ALSE F ALSE F ALSE 


F ALSE F ALSE F ALSE T RU E
The SMP algorithm is applied to gene annotations within each GO term in Chapter
3.2.4.
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Chapter 2
Motivation
The primary purpose of this thesis is to explore gene annotation in the building of
gene set lists and address the problem of gene annotation ambiguity in mvGST analyses.
The current R package mvGST has limited annotation capabilities and provides temporary
methods for handling annotation ambiguities. Current methods and limitations of gathering
annotations by mvGST are discussed in Chapter 1.5.2.
To conduct mvGST analysis, one must have an experiment’s matrix of p-values (see
Chapter 1.3) and a list of meaningful gene sets or groupings. The matrix of p-values used
by the meta-analytical methods in mvGST are platform-independent, but the process of
building gene set lists is not. Two example studies are discussed in this thesis. Study 1 was
selected to compare mvGST results under current mvGST annotation methods to mvGST
results under annotation methods proposed in this thesis. Study 2 was selected to illustrate
the added flexibility the proposed annotation methods bring to mvGST analysis. Study
2 also provides an example to demonstrate the proposed SMP algorithmic alternative for
handling annotation ambiguities.
All data from the two example studies are simple completely randomized designs and
have been obtained through the public repository Gene Expression Omnibus on the NCBI
website. A useful interface to this repository has been provided for R users with the package
GEOquery [31].

2.1

Example Study 1
Example Study 1 has GEO accession number GSE47776. An experimental summary

and the model set-up used in this thesis are subsequently provided.
The corpus luteum (CL) is a temporary structure in the ovary that forms with each

18
menstrual cycle. Degradation of the CL leads to abortion, and understanding the activity
of biological processes in the CL is of interest to researchers of reproductive performance.
A study at Colorado State University tested the hypothesis, “gene expression differs
in corpus luteum (CL) collected from pregnant (P) and non-pregnant (NP) ewes [4].” The
Affymetrix Bovine Genome Array platform was used.
To test this hypothesis, six microarray samples were taken at Day 12 for three pregnant
ewes and three non-pregnant ewes. Six more microarray samples were taken on Day 14
for three different pregnant ewes and three different non-pregnant ewes. The different
treatments can be summarized as three replicates of the following:
P 12: Pregnant ewes at Day 12
P 14: Pregnant ewes at Day 14
N P 12: Not Pregnant ewes at Day 12
N P 14: Not Pregnant ewes at Day 14
Researchers involved in this study used their own models to test their hypothesis. In
this thesis, the following contrasts can be constructed to test for the effect of pregnancy at
each day by comparing expression profiles with the following contrasts:

1. H0 : P12 − N P12 = 0
2. H0 : P14 − N P14 = 0

Despite the study involving female sheep, the Affymetrix Bovine Genome Array platform was used to gather measures of gene expression. This array is GO-annotated and is
supported by mvGST annotation methods. mvGST annotation methods will be compared
to Biomart and Affymetrix annotation gathering methods in Chapter 3.1. The results can
be found in Chapter 4.2.

2.2

Example Study 2
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Example Study 2 has GEO accession number GSE52888. Additional platform annotation was provided by researchers at the Wood Lab of the University of Florida and was
accessed by specifying the accession number GPL14112 [5]. This specific annotation is used
in Chapter 3.2 in building a list of GO gene sets, the elements of which are the probeIDs
of the microarray platform used in the study.
In this study, hypothalamic mRNA expression profiling was obtained using array
Agilent-019921, a sheep gene expression array platform. Chronically catheterized fetal
sheep were subjected to the following treatments:
C: Control (no treatment)
T1 : Brachiocephalic Occlusion (BCO) Treatment (10 min., no other treatment)
T2 : Estradiol Plus Brachiocephalic Occlusion Treatment
T3 : Estradiol Treatment (250 ug/day x 5 days)
There are four replicates of each treatment resulting in sixteen samples total. The
Agilent array has 15008 unique probeIDs. In this thesis, meaningful contrasts to investigate
the differences due to treatment type will be tested in the following way:

1. H0 : T1 − C = 0
2. H0 : T2 − C = 0
3. H0 : T3 − C = 0

The Agilent-019921 microarray is an example of what in this thesis will be termed
a novel microarray for a non-model organism because probeID-to-GO annotation is not
available using the current mvGST annotation methods. It should be noted that the terms
“novel” and “non-model” are used differently elsewhere and were encountered in researching
GO annotation files [19].
mvGST fails to annotate this platform for the following two reasons:
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1. The organism Ovis aries is not a supported parameter in mvGST
2. Mappings from probeIDs to a GO annotated gene naming convention are unavailable
with current mvGST annotation gathering methods.
Both constraints have been addressed with methods described in Chapter 3.2. For
brevity, GO annotated gene naming conventions will be referred to as GOgncs.
When probeID-to-GO mappings are unavailable, a GOgnc can be used as a translator. mvGST has implemented a strategy that first takes probeIDs and maps them to
GO-annotated Entrez IDs and then maps the probeIDs to GO terms. This strategy for
annotating probeIDs to GO is limited in two ways. First, only Entrez is considered as a
GOgnc translator. Second the function gconvert (used by mvGST to convert probeIDs to
Entrez) is limited to non-novel platforms currently supported by Ensembl. The Agilent019921 microarray is not supported in Ensembl’s Biomart.
If a GOgnc translator must be used to map to GO terms, there is a potential for
translation ambiguities to occur. Many-to-one and one-to-many translation ambiguities
that have the potential to bias mvGST analyses are discussed in mvGST: Tools For Multivariate and Directional Gene Set Testing [20]. The thesis proposes and includes solutions
within mvGST to handle translation ambiguities, but acknowledges them as temporary and
somewhat unsatisfying. This has motivated the development in Chapter 3.2.4 of an SMP
algorithmic approach for handling translation ambiguities by optimally choosing among
ambiguous annotations based on measures of annotation strength.
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Chapter 3
Methods
The first consideration in building GO gene set lists for use in mvGST is to consider
the existence of probeID-to-GO annotation. If such annotation is available, then there is
no need for use of a GOgnc translator to provide probeID-to-GO mappings. Consequently
when such annotation is available, ambiguous potentially biasing mappings are avoided.
Example study 1 is an example where such is the case. When probeID-to-GO annotation is
not available, a GOgnc with annotation to the probeIDs on the microarray can be used to
build a meaningful list of GO gene sets. These GO gene sets can then be used in mvGST
analysis.

3.1

Example Study 1
To begin mvGST analysis of Study 1, an expression set matrix (see Chapter 1.3.1 and

Table 1.4) was uploaded into R using the getGEO function of the GEOquery package and
the study’s GEO accession number.
Next, a matrix of p-values is obtained through use of the R package limma (see Chapter
1.4.1). Table 1.3 shows the header for this matrix of p-values. Notice that the contrasts
of interest in the matrix of p-values represent the same contrasts described in Chapter 2.1.
This matrix of p-values will be used here in three different calls to mvGST’s profileTable
function, for demonstration purposes.
ProbeID-to-GO annotation is available for the bovine Affymetrix platform used in
example Study 1. The appropriateness of using a bovine microarray in a study involving
sheep lies outside the scope of this thesis.
Example Study 1 was chosen specifically for comparison purposes. The following three
main sources of probeID-to-GO annotation were considered in building the appropriate GO
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gene set lists for this study:
1. mvGST (Chapter 3.1.1).
2. Ensembl’s Biomart (Chapter 3.1.2).
3. Affymetrix (Chapter 3.1.3)
These three sources provide enough information to construct GO gene set lists, the
differences of which are discussed in Chapter 4.

3.1.1

mvGST Annotation

The most convenient of all methods considered in this thesis for constructing a list
of GO gene sets is to call the annotation arguments in mvGST’s profileTable function.
The function was designed to build the list automatically before mvGST analysis. An
appropriate example of profileTable arguments for example study 1 are detailed below:
profileTable(pvals.study1, sig.level = 0.05, gene.ID = "affy",
organism = "btaurus", affy.chip="bovine.db", ontology = "BP",
method = 2, minsize = 1, maxsize = Inf, mult.adj = "BY")
By specifying these annotation arguments, this call to profileTable will build a list
of GO gene sets for Bos taurus biological processes. It should be noted that elements of
this list are GO terms where each is populated with the row names of the p-value matrix.
In this example, genes within each GO gene set are Affymetrix probeIDs.

3.1.2

Biomart Annotation

The second method for constructing a list of GO gene sets for Study 1 considers the
use of the R package biomaRt to query the Ensembl database. The following was used to
appropriately query the Ensembl database for Study 1.
ensembl_80_btaurus <- useMart(biomart="ENSEMBL_MART_ENSEMBL",
host="may2015.archive.ensembl.org",
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path="/biomart/martservice",
dataset="btaurus_gene_ensembl")

annotation <- getBM(attributes=c(’affy_bovine’, ’go_id’, ’namespace_1003’),
values=T, mart = ensembl_80_btaurus)
The resulting structure for a similar example of a Biomart query can be seen in Chapter
1.6.3. Here the latest version of the btaurus gene ensembl dataset was used. The getBM
function allows for specific queries to this organism-specific dataset. To build a list of GO
gene sets similar to the list built with mvGST annotation methods, three attributes of
annotation for the Affymetrix Bovine array must be obtained. They include Affymetrix
probeIDs, GO IDs, and the domains for GO ID. Each row in this resulting data frame is
unique and may contain cells of missing data. Before constructing the list of GO gene sets,
it is appropriate to subset the data to only include rows with all three pieces of annotation
information and limiting the rows to only include probeID-to-GO annotations describing
biological processes. This sub-setting will ensure GO gene sets have at least one gene
(equivalent to the minsize=1 argument in mvGST’s profileTable function).
The hierarchical structure of GO necessitates obtaining the offspring GO terms for
each GO term already in the list and including them as separate gene sets in the list.
This procedure was done using code from mvGST’s profileTable function. The mvGST
package gathers GO-offspring information using the GO.db package.
Computation time to query Biomart takes anywhere from 2-5 minutes and depends on
the user’s internet connection speed. The construction of this particular list of gene sets for
the bovine Affymetrix array took about 5 minutes. This computation expense is larger but
comparable to mvGST’s annotation methods.
Below are gene sets five and six of the list constructed using this method. These sets
correspond to specific biological processes and contain five and one gene(s), respectively.
$‘GO:0000019‘
[1] "Bt.27218.1.A1_at" "Bt.24555.1.S1_at" "Bt.17276.1.A1_at" "Bt.7008.1.S1_at"
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"Bt.894.1.S1_at"
$‘GO:0045950‘
[1] "Bt.894.1.S1_at"

3.1.3

Affymetrix Annotation

The third method one may employ to gather probeID-to-GO annotation is to go straight
to the microarray manufacturer. Depending on the structure of the annotation file provided
by the manufacturer, this method can prove to be tedious.
A .csv file was downloaded from Affymetrix’s annotation web page and read into R.
The file is rather large at approximately 50 Mb and contains probeID-to-GO annotation.
There are two columns in this file which contain all the information needed to build the
GO gene set list for biological processes (BP). The most difficult part in using this file was
extracting each unique GO term among descriptions of the GO terms. To accomplish the
task of identifying each GO term and extracting them from the file, a regular expression
was used to search for the 7 digit sequence common in all GO ID terms. The R code used
to accomplish this task can be found in the Appendix. After all GO terms were extracted
and put in list form, the original file was then used again to populate each GO term with
probeIDs annotated to each GO term.
The computation time for this process took over an hour, much longer than the previous
two methods considered in example Study 1. The results, however, were encouraging and
are discussed further in Chapter 4.

3.2

Example Study 2
A matrix of p-values was obtained using the methods described in Chapters 1.3.1,

1.4.1, 1.4.2, and the contrasts described in 2.2. It was mentioned in Chapter 3 that when
probeID-to-GO annotation is not available, then annotation from a GOgnc translator must
be used (see Chapter 2.2). The idea is to follow probeID-to-GOgnc-to-GO in order to obtain
probeID-to-GO annotation. When using a GOgnc translator, annotation ambiguities are
introduced and should be corrected prior to mvGST analysis. The goal of the methods
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described in the subsequent sections is to provide an SMP-algorithm-optimized list of GO
gene sets for Ovis aries biological processes. The genes within each GO set of the resulting
list will be probeIDs from the Agilent-019921 Sheep Gene Expression Microarray.
For this example, the complete computation time to construct the final GO gene set
list is approximately 15 minutes. This expense includes multiple queries to Biomart.

3.2.1

ProbeID-to-GOgnc Annotation

ProbeID-to-GOgnc annotation for novel arrays are often not found in annotation repositories. Such is the case with the Ovis aries Agilent-019921 microarray. No annotation for
this array is found in Ensembl’s Biomart. The gene naming conversion methods used in
mvGST also fail because they also use information provided by Ensembl (see Chapter 2.2).
Two annotation sources were obtained for Agilent-019921– the manufacturer’s annotations and those provided by Charles Evans Wood’s research group [5]. GOgnc candidates
will be considered and compared from both sources of annotation, but first a quick glance at
the annotation available under each gene naming convention (gnc) can be found in Tables
3.1 and 3.2.
Table 3.1: GOgnc Candidates: Agilent Source

ProbeID
PrimaryAccession
RefSeqAccession
GenbankAccession
UniGeneID
EntrezGeneID
GeneSymbol
GeneName
EnsemblID
TIGRID
GO
Description
GenomicCoordinates
Cytoband

Annotated

Uniquely Annotated

Duplicated Annotation

1
0.910
0.470
0.860
0.770
0.210
0.210
0.210
0
0.680
0.020
0.900
0
0

1
0.810
0.320
0.770
0.680
0.110
0.110
0.110
0
0.560
0.010
0.800
0
0

0
0.110
0.330
0.110
0.120
0.490
0.490
0.490
0
0.180
0.130
0.110
0
0
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Table 3.2: GOgnc Candidates: Wood Research Lab Source

ID
GeneName
ORF
Approved Name
GB ACC
SPOT ID

Annotated

Uniquely Annotated

Duplicated Annotation

1
1
0.820
0.810
0.860
0.010

1
0.920
0.390
0.380
0.860
0.010

0
0.080
0.530
0.530
0
0.100

These tables were created using the function quickView provided in the Appendix.
The “ProbeID” and “ID” naming conventions found in the first rows of Tables 3.1 and
3.2 identically contain the names of the probeIDs associated with the microarray Agilent01992. It can be seen in the tables that each probeID (ID) is unique. This is important
when considering probeID-to-GOgnc annotation ambiguities. The uniqueness of probeIDs
in this example indicate that only one-to-many type ambiguities can occur. It is also of
value to notice that only 0.020 of the probeIDs have some sort of GO annotation. This fact
illustrates what is meant by probeID-to-GO annotation not being available.
Tables 3.1 and 3.2 not only provide the names of all possible GOgnc translators one
might consider, but also give a preliminary indication as to which would make the best candidates. The column “Annotated” can be interpreted as showing the proportion of probeIDs
that have some sort of annotation for each row gnc. EntrezGeneID, for example, has annotation for .21 of the probeIDs on the microarray. EntrezGeneID has unique annotation for
only .11 of the probeIDs. Also, there are 0.210 ∗ 15, 008 = 3, 152 probeID-to-EntrezGeneID
annotations, of which .49 are duplicated at least once. The column “Duplicated Annotations” is an indication of the magnitude of translation ambiguities present. More specifically,
when taking into consideration the fact that all the probeIDs are unique, these duplications
indicate the magnitude of potentially biasing one-to-many translation ambiguities.
One might conclude that the best GOgnc translator candidates are “PrimaryAccession”, “GenbankAccession”, “Unigene”, “TIGRID” from Agilent and “GeneName”, “ORF”
and “GB ACC” from the Wood research group. However, such conclusions based on these
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tabulations are premature. The performance of each of these naming conventions in mapping to probeIDs has been quantified but not their ability to map to GO. The gene naming
convention that most successfully maps to both probeIDs and GO terms is the most appropriate GOgnc translator.

GOgnc Potential Performance
GOgnc-to-GO annotations are obtained using Ensembl’s Biomart in a Biomart query
similar to that described in Chapter 3.1.2. The R function gncTranslate (see Appendix)
was created to merge two annotation bi-maps, one for the probeID-to-GOgnc bi-map as
provided by either Agilent or the Wood research group, and one for the GOgnc-to-GO
bi-map as provided by Ensembl’s Biomart. The output of this function is useful because
it provides the annotation matrices needed to build the list of GO gene sets and also
performance metrics for the GOgnc translator after mapping to GO. GenbankAccession
annotations given by Agilent provide the best example of a gnc that has a high “Annotated”,
“Uniquely Annotated”, and a low “Duplicated Annotation” combination, yet, it does not
map well to GO.
The following was executed in R and yields translation performance metrics for GenbankAccession after mapping to GO in Table 3.3.
agilent.gnc.GB_ACC <- gncTranslate(probe.embl,embl.go,"embl",agilent$ProbeID)
agilent.gnc.GB_ACC[[3]]

Table 3.3: Translation Performance Metrics for GB ACC

1

gncs

probe ids

annotations

go ids

chipCoveragePotential

139

214

214

1097

0.01425906

The metric “chipCoveragePotential” in Table 3.3 is the number of microarray probeIDs
with annotation to at least one GO term over the total number of unique probeIDs. The
probeIDs with GO annotation have the “potential” to be used in mvGST analysis. After the
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SMP procedure for Study 2 (see Section 3.2.4), the final “chipCoverage” metric is reported
in Chapter 4.2.
It can be seen from Table 3.3 that there are only 139 unique GenBankAccession identifiers that map to probeIDs and GO terms of biological processes (BP). These 139 GenBankAccession identifiers map to 214 probeIDs and 1,097 different GO terms of BP. The
matrix of p-values has a p-value associated with each probeID which means only 214 p-values
will be used in subsequent mvGST analysis. This is only .0141 of the 15,008 probeIDs represented on this microarray chip. The best candidate for use in construction of the GO list
will have the most GO terms and the highest chipCoveragePotential. The term potential
is important because ambiguities have not yet been accounted for. After using the smp
function that will be described in Chapter 3.2.4 the final chipCoverage will be reported in
Chapter 4 and will always be less than the chipCoverage Potential.
By comparing gncs, probe ids and annotations, one can get an idea of the magnitude
of annotation ambiguity. As illustrated in Table 3.3 there are 214 probeID-to-GOgnc annotations and 214 probe ids. One can conclude from this that each probeID-to-GOgnc
annotation is unique because each probeID is unique. This is why both columns report
the same number of 214. Notice that there are fewer GOgncs than probeIDs illustrating
that there are many-to-one (many probeIDs to one GOgnc) annotation ambiguities only.
In other words, there are no one-to-many ambiguities.
Table 3.4 gives the performance metrics for different GOgnc translators after mapping
to GO BPs for each of the two sources of annotation information. The results are surprising
in that the GOgncs that initially looked like good candidates from output provided by the
quickView function, see Tables 3.1 and 3.2, turned out to map poorly to GO (i.e. had low
chipCoveragePotential and low numbers of unique GO gene sets).
The structure of the Wood annotation file consists of rows that contain microarray
probeIDs and columns that specify different gncs. The annotation provided by the Wood
Research Group was difficult to work with because multiple GOgncs were found under a
single column. The term ORF (a column in the file) in fact refers to Open Reading Frame
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Table 3.4: Translation Performance Metrics for Candidate GOgncs

Agilent GB ACC
Agilent Unigene
Agilent EntrezID
Agilent RefSeq
Wood GenBank
Wood ORF

GOgncs

probeIDs

Annotations

GO

chipCoveragePotential

139
2661
1627
3030
0
5121

214
3025
2217
3763
0
7298

214
3025
2217
3763
0
7298

1097
5050
4552
5348
0
6698

0.01425906
0.2015592
0.1477212
0.2507329
0
0.486274

which is not even a gnc let alone a GOgnc. After exploring the “ORFgnc” in the Wood
annotation file, the majority of entries were comprised of GenBankAccession numbers and
HGNC symbols (HUGO Gene Nomenclature Committee Symbols [32]. It can be seen in
Table 3.4 that the Wood GenBankAccession did not provide any annotations and many
of these same GenBankAccession numbers are found in ORF. The reasonable step then
was to consider only querying Biomart for HGNC Symbols found within the ORF column.
This proved to be the best performing GOgnc with 6,698 unique GO terms, 5,121 unique
GOgnc identifiers, and 7,298 unique probeIDs. The chipCoveragePotential was also by far
the highest at 0.486274. These probeID-to-HGNC-to-GO annotations were selected to build
GO gene sets.

3.2.2

Build GO Gene Sets

Here the function groupBuilder (see Appendix) was used to group probeID-to-HGNC
annotations by GO terms. Using the results from Chapter 3.2.1, the call to groupBuilder
took approximately 4-5 minutes. Some smaller elements of the resulting list are shown
below.
$‘GO:0001869‘
gnc
3

probe_id

A2M A_70_P017696

37941 SERPING1 A_70_P058611
$‘GO:0006103‘
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gnc
9

probe_id

AADAT A_70_P005451

42002 STAT5B A_70_P022711
42059 STAT5B A_70_P017016
42884

TAT A_70_P037681

The second GO term in the output (‘GO:0006103’) illustrates two ambiguous annotations, namely:
42002 STAT5B A_70_P022711
42059 STAT5B A_70_P017016
STAT5B is a HGNC symbol identifier that is annotated to two different probeIDs
(A 70 P022711 and A 70 P017016). These annotation ambiguities within each GO term
will be handled using the proposed SMP procedure (see Chapter 3.2.4).

3.2.3

Sequence Alignments as Measures of Annotation Strength

Prior to selecting the optimal annotations within each GO group, a measure of strength
for each annotation must be calculated. It was proposed to use sequence alignment similarity scores as a way of measuring the strength or quality of each annotation. The
pairwiseAlignment function in the Biostrings R package was used to conduct local-global
sequence alignments. When considering what alignment type to perform, look at the
Biostrings package help file. The local-global sequence alignment seemed most appropriate
in this example as probeID sequences from this array are much smaller (60-mer) than the
GO-gnc sequences.
Sequences were gathered in a Biomart query for each HGNC Symbol and each probeID
found in the GO list produced in Chapter 3.2.2. The 60-mer oligonucleotides sequences for
the probeIDs are all uniquely mapped in a 1-1 relationship. The HGNC symbols however
were not. The cDNA transcripts associated with each HGNC Symbol are Ensembl transcripts. Some HGNC Symbols have multiple Ensembl cDNA transcripts. This observation
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was noticed when the number of unique sequences (5718) and unique HGNC Symbols (5121)
resulted in unequal numbers. It should be noted there are more transcript sequences than
HGNC Symbols and also each HGNC Symbol is unique. This means there are only many
sequences-to-one HGNC ambiguity type, as in the example in Chapter 3.2.2. This fact will
be important when considering the proposed solution.

3.2.4

SMP

The SMP algorithm discussed in Chapter 1.7 will be applied to annotations in each
GO term. Preferences are determined by sequence alignment scores. The procedure returns
the maximum number of optimally “stable” 1-1 annotations within each GO term.
The solution chosen to handle sequence-gnc ambiguities was first to consider each annotation in the GO-grouped list from Chapter 3.2.2. For each HGNC in the list with multiple
sequences, the sequence that maximized the alignment score when aligned to the probeID
sequence to which it was annotated was chosen. This procedure seemed the natural solution
for handling these sequence-gnc ambiguities in context of what is desired. This endeavor
was initially very challenging and computationally expensive, inspiring the annotator function (in Appendix) to limit the amount of string matches made by the smp function. The
changes in the manner of string comparison by the annotator function drastically reduced
the computation time when calling the smp function.
There are multiple procedures embedded in the smp function and will not be discussed
in detail here (see R code in the Appendix). As an overview, the function takes as arguments
results from Chapter 3.2.3. The first procedure executed by smp is to obtain the maximum
sequence alignment score for each annotation in each GO group. Then each probeIDto-GOgnc annotation (in this example probeID-to-HGNC Symbols) in each GO group is
ordered according to GOgnc and then by alignment score. This ordering is important when
building the matrix of preferences for each GOgnc (see Chapter 1.7). The same ordering
methodology is done for the probeIDs to rank their preferences of GOgncs. Finally, for
each GO group the daa function (see Chapter 1.7) is called and returns optimal probeIDto-GOgnc pairings. The result is the desired list of GO grouped probeIDs.
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Similar to methods described in Chapter 3.1.2, the hierarchical structure of GO is
accounted for using code from mvGST. This step is the last so the resulting list can then be
used in mvGST analysis. Displayed below are some of the smaller elements of the resulting
list.
$‘GO:0000002‘
[1] "A_70_P062131" "A_70_P026981" "A_70_P071411" "A_70_P061636"
[5] "A_70_P062171" "A_70_P022551" "A_70_P045001" "A_70_P025356"
[9] "A_70_P020636" "A_70_P049666" "A_70_P049667" "A_70_P002736"
$‘GO:0000012‘
[1] "A_70_P063286" "A_70_P052106" "A_70_P039931" "A_70_P061911"
$‘GO:0000019‘
[1] "A_70_P010796" "A_70_P028691" "A_70_P024591"
This output contains three GO terms (GO:0000002, GO:0000012, GO:0000019) each
of which correspond to a biological process. The elements within each GO term are the
probeIDs corresponding to the Agilent-019921 microarray. The GO terms in the list could
have easily been populated with HGNC symbols instead of microarray probeIDs. For greater
interpretability, researchers may prefer GO gene set lists populated by gncs rather than
probeIDs.

3.3

Custom R Annotation Packages
Creating custom organism-specific annotation packages within R was investigated as

an annotation-gathering option. The idea was to create annotation packages for organisms
currently not supported by mvGST and add them prior to mvGST analysis. This method
was abandoned after creating annotation packages for Study 1 and Study 2.
Two annotation packages were created, one a Bos taurus package for Study 1 and
another Ovis aries package for Study 2. These annotation packages were built using the
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makeOrgPackageFromNCBI function from the AnnotationForge package [26]. Both annotation packages contained information for multiple gncs and transcript sequences, but as
compared to Biomart the selection was limited.
The custom-built Bos taurus package did not contain Affymetrix-to-GO annotation
unlike the annotation package for Bos taurus used by mvGST annotation methods. With
Affymetrix-to-GO annotation being available through both Biomart and Affymetrix’s own
annotation file, the failure of the custom annotation package approach to provide direct
GO annotation would have unnecessarily required a GOgnc translator. Translating unnecessarily would have introduced avoidable translation ambiguities. This result was taken as
evidence that this method of annotation was not as complete as others considered in this
thesis.
The custom Ovis aries package likewise did not contain probeID-to-GO annotation,
but this time Biomart also failed to produce direct GO annotation. The main strike against
the custom Ovis aries package was that it contained a paltry selection of GOgncs compared
to Biomart. It became evident that a custom Ovis aries package would never be preferred
to using Biomart as a method of implementing GOgnc translators.
As a final note, both packages took over three hours to compile. This expense can be
compared to a Biomart query that ranges from 3-5 minutes.
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Chapter 4
Discussion
For Study 1, the three GO gene set lists constructed in Chapter 3.1 are compared. The
results of mvGST analysis using each of the three lists are also compared and discussed.
The performance metrics for the Ovis aries GO gene set list for Study 2 constructed
in Chapter 3.2 are reported. mvGST results for Study 2 are also shown and discussed.
To conclude, a brief discussion about possible extensions to this work is presented.

4.1

Study 1 Discussion
Study 1 allowed for the comparison of three different GO grouped Bos taurus gene set

lists. Somewhat surprisingly, the GO gene set lists vary widely depending on what method
is used to build them. Two metrics were considered in assessing which list would be best
to use in mvGST analysis– 1) the number of unique GO identifiers in each list and 2) the
number of unique probeIDs in each list relative to the number of probeIDs on the microarray
(chipCoverage).
The justification for choosing these two metrics is that no annotations were created
from methods discussed in this thesis and so the probeID-to-GO annotations were simply
gathered from different sources. Assessing the quality of annotation lies outside the scope
of this thesis. Therefore, the annotation-gathering method that yields the highest quantity
of annotation is considered the most appropriate. A brief note on annotation quality is
mentioned in Chapter 4.3
Figure 4.1 illustrates a visual comparison for the three different GO gene set lists built
in Chapter 3. The best-performing list in this figure would be the list closest to the upper
right corner. What can be seen in the plot is that the annotation method provided by
mvGST is the lowest performing method.
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It is unclear which method is preferred when comparing the annotation provided by
Biomart and Affymetrix. The list constructed using annotation from Affymetrix provides
greater chipCoverage whereas the list constructed using annotation from Biomart has more
unique GO identifiers.

4.1.1

Compare GO Grouped Lists

The list performance plot in Figure 4.1 should be used to select the most appropriate
GO gene set list. Additionally, by comparing each of the three lists to each other, conclusions
about annotation concordance among the lists can be reached.
To compare lists to each other, four different list grouping comparisons were made.
They are: Biomart/Affy, Affy/mvGST, Biomart/mvGST, and Biomart/Affy/mvGST, see
Figure 4.2. Three criteria were used in the comparisons– 1) GO IDs, 2) probeIDs, and
3) Gene Sets. The proportion concordant for GO ID terms is the number of unique GO
ID terms that match in all lists of a given comparison over the number of unique GO ID
terms found in any one of the lists of a given comparison. The proportion concordant for
the probeID criterion is similar– it’s the number of probeIDs common to all lists in a list
grouping comparison over the number of probeIDs found in any one of the lists in a list
grouping comparison. The Gene Sets criterion considers both GO IDs and their probeID
elements. The proportion concordant for Gene Sets is the number of GO IDs with exactly
the same probeID elements in all the lists of a given comparison over the number of GO
IDs found in any one of the lists in the comparison.
Figure 4.2 illustrates that the GO gene set lists constructed using annotation from
Biomart and Affymetrix are the two most similar lists. Of the total unique GO IDs and
probeIDs among these two lists, approximately .78 and .74 of them are in both lists, respectively. Other list comparisons have lower values for the GO ID and probeID criteria. When
considering the comparison groupings, this decrease is attributable to the mvGST method
of gathering annotation.
The fourth grouping (Biomart/Affymetrix/mvGST) is an interesting comparison because it indicates the proportion of concordance among all the lists. The proportion of
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List Performance Plot
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Chip Coverage
Fig. 4.1: List performance is based on two metrics: 1) the total unique GO Identifiers
included in the list (vertical-axis) and 2) how many unique probeIDs are included in at
least one GO gene set (horizontal-axis). The best performing list will have the highest
values for both.
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concordance for GO IDs and probeIDs seems low, just less than .75, but most surprising
might be the proportion of gene sets common to all three lists. This value stands at less
than two percent. This result indicates that less than two percent of the GO gene sets
among the lists are evaluated equally when mvGST analysis is performed.

4.1.2

Compare mvGST Analysis Results

The proportion of GO gene sets for each list identified as significant (or not) by mvGST
analysis can be seen in Figures 4.3 and 4.4 for Day 12 and Day 14, respectively. The results
from mvGST analysis were similar for each list in the proportion it identified as either
not significant, more active, or less active in Day 12; however, the list built by mvGST
annotation methods showed a slightly greater proportion of the GO gene sets identified as
more active compared to the other two lists. Consequently, the added proportion identified
as more active corresponds to a lesser proportion of GO gene sets identified as less active as
compared to the other two lists. These observations further demonstrate that the similarity
between the Affymetrix and Biomart created lists, shown in Chapter 4.1.1, can be seen after
mvGST analysis.
Figures 4.3 and 4.4 also demonstrate that the dissimilarity of the gene sets among the
lists doesn’t overly bias the proportion of gene sets identified as either significantly more
active, less active, or not differentially active as the proportions are very similar regardless
of which list was used in the analysis.

4.2

Study 2 Discussion
Study 2 provided an example of a novel microarray whose probeIDs could not be

directly mapped to GO. As a solution, a GO-annotated gnc was selected as a translator of
sorts to map probeIDs to GO terms. Different GO-annotated gncs performed with varying
results as translators for the microarray. It has been mentioned that the ORF column in the
annotation file provided by the Wood lab is not a gnc and is mostly comprised on HGNC
symbols (see Chapter 3.2.1). The HGNC symbol gnc was selected as the best-performinggnc translator because it yielded the highest performance metrics (see Table 3.4).
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List Comparisons Plot
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Fig. 4.2: Proportion concordant signifies the proportion of either GO IDs, Gene IDs, or
Gene Sets that are found in all lists within the different list comparisons (found at vertical
axis). GO IDs indicate the unique names of GO terms. Gene IDs are the unique gene
identifiers. Gene sets consider both GO identifiers and their gene identifier elements.
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List Comparison of mvGST Analysis Results: Day 12
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Proportion of GO Gene Sets
Fig. 4.3: Illustrates the proportion of GO Gene Sets that are either significantly more
active, less active, or not differentially active in each list after mvGST analysis. Further
explanation of the contrast of interest tested here, H0 : P12 − N P12 = 0, can be found in
2.1.
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List Comparison of mvGST Analysis Results: Day 14
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Fig. 4.4: Illustrates the proportion of GO Gene Sets that are either significantly more
active, less active, or not differentially active in each list after mvGST analysis. Further
explanation of the contrast of interest tested here, H0 : P14 − N P14 = 0, can be found in
Chapter 2.1.
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Sequences were then gathered for each probeID and each HGNC symbol identifier.
Working within the probeID-to-HGNC symbol annotation framework, sequence alignments
were performed to get measures of strength for each annotation. The maximum measure
was selected for HGNC symbols with multiple sequences. The SMP method for selecting the
most appropriate 1-1 mapping between probeIDs and HGNC symbols was then employed for
each GO term containing at least one HGNC symbol. Instead of populating GO terms with
HGNC symbols, probeIDs were used to populate the GO gene set list. Parent GO terms
of GO terms of this list were then obtained and populated with their GO term offspring
probeIDs accounting for the hierarchical structure of the gene ontology.

4.2.1

GO Gene Set List: Ovis aries Microarray

The Ovis aries Agilent-019921 microarray was used in Study 2. A summary of the
constructed GO gene set list can be found in Table 4.1.
Table 4.1 shows that all GO identifiers in the list are unique. This was expected
and only mentioned here as a check. The chipCoverage metric is truly interesting. The
chipCoverage metric is defined as the number of probeIDs used in mvGST analysis over
the total number of probeIDs on the microarray. Notice that the chipCoverage for this
list is 0.388. This value is approximately ten percent lower than the chipCoveragePotential
reported in table 3.4 (the chipCoveragePotential in Wood ORF). This loss in chipCoverage
is attributable to the SMP procedure described in Chapter 3.2. It is important to note that
the unique number of probeIDs included in the final analysis is 5,823, a number between
the reported number of unique GOgncs (5,121) and probeIDs (7,298) prior to the SMP
procedure. If the SMP method were done on the annotations prior to grouping them by
GO, the result would have been a total of 5,121 unique probeIDs used in mvGST analysis
due to the fact that the SMP method always returns a 1-1 mapping. Though somewhat
computationally expensive, doing the SMP procedure within each GO term allowed 702
probeIDs to be included in the final analysis that otherwise would not have been.
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Table 4.1: Agilent-019921 GO Gene Set List Summary

4.2.2

Unique probeIDs

GO IDs

GO IDs

chipCoverage

5, 823

10, 082

10, 082

0.388

mvGST Results

The results of mvGST analysis for Study 2 are stand-alone results and are reported in
Table 4.2 for completeness. An example of interpretation from Table 4.2 can be expressed–
there are 24 biological processes differentially more active (indicated by a 1) in the estradiolplus-brachiocephalic-occlusion (EBO) treatment group with no significant activity difference
(indicated by a 0) in the brachiocephalic-occlusion (BO) and estradiol (E) groups, when
compared to the control group. The other four rows can give similar interpretations.
For further methods to identify which gene sets are included in each profile, see mvGST:
Tools For Multivariate and Directional Gene Set Testing [20].
Table 4.2: mvGST Analysis Results for Study 2
BO-C

EBO-C

E-C

BP

0
0
0
0

0
0
1
1

0
1
1
0

9, 745
271
42
24

Without the methods and tools developed as part of this thesis, the Ovis aries results given in Table 4.2 could not have been obtained using mvGST because Study 2 was
conducted with a less traditional platform in a non-model organism.

4.3

Potential Extensions
In the process of developing the methods described in this thesis, a few possible exten-

sions were discovered but not fully explored.
In constructing the GO gene set list for Study 2, probeID-to-GO-gnc (HGNC symbols)
annotation was considered. There is no compelling reason that multiple GO-gnc translators
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could not be used. Doing so would likely increase both final chipCoverage and the number
of GO terms used in mvGST analysis.
Using multiple GO-gnc translators would use more completely the annotation available.
Where one probeID failed to map to a specific GO-gnc, there may be a mapping of that
same probeID to a different GO-gnc. The SMP procedure would ensure that multiple pvalues associated with the same probeID would not be included multiple times in any given
GO gene set. Multiple queries to Biomart may have to be done to accomplish this task.
Nevertheless, resulting lists constructed using multiple GO-gncs would be more complete.
When considering Agilent RefSeq as a GO-gnc translator in Chapter 3.2, two queries
were made to Biomart because it was unclear which gnc in Biomart was appropriate. The
code used to query Biomart for RefSeq can be used as an example of using multiple GOgncs
as translators.
Another possible extension is to consider how measures of annotation appropriateness
are to be calculated. These measures provide mapping preferences used in the SMP procedure for each probeID and each GO gene identifier. They ultimately determine how ambiguities are handled. In this thesis, the pairwiseAlignment function (from the Biostrings
package [33]) returned sequence similarity scores for type local-global alignments as measures of annotation appropriateness. More sophisticated methods for assessing annotation
strength may be employed and used by the SMP procedure presented in this thesis.
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Appendix
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library(GEOquery)
library(limma)
library(mvGST)

#################################
#Obtain Data for Example Study 1
#################################

#Get the expression data#
EsetGSE47776 <- getGEO("GSE47776",GSEMatrix=TRUE)
#It reads in as a list of length one. Point to the ExpressionSet and save as an
object
#so that it can be used in the global environment.
EsetGSE47776 <- EsetGSE47776$GSE47776_series_matrix.txt.gz

#Some functions used to explore an expression set object
#class(EsetGSE47776)
# featureNames(EsetGSE47776)[1:5]
# fvarLabels(EsetGSE47776)
#sampleNames(EsetGSE47776)
#varLabels(EsetGSE47776)

##################################################################
#Limma\eBayes to test DE among genes across contrasts of interest
#Results in a matrix of p-values
##################################################################

#Extract matrix of expression values
mat <- exprs(EsetGSE47776)
#Name columns appropriately where each column identifys a particular sample
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colnames(mat) <- c("Day12.P","Day14.P","Day12.NP","Day12.NP","Day12.NP","Day14.P",
"Day14.NP","Day12.P","Day12.P","Day14.NP","Day14.P","Day14.NP")
#Define treatments, fit linear model
Treatment <- as.factor(c("Day12.P","Day14.P","Day12.NP","Day12.NP","Day12.NP","
Day14.P","Day14.NP","Day12.P","Day12.P","Day14.NP","Day14.P","Day14.NP"))
#Define design matrix
design <- model.matrix(~0+Treatment)
colnames(design) <- c(’Day12.NP’,’Day12.P’,’Day14.NP’,’Day14.P’)
#Fit linear model
fit <- lmFit(mat, design)

#Test 1st contrast
contrast1 <- makeContrasts(Day12.P-Day12.NP, levels=design)
fit1 <- contrasts.fit(fit, contrast1)
final.fit1 <- eBayes(fit1)
top1 <- topTableF(final.fit1, adjust.method="BH", n=nrow(mat), sort.by="none")

#Test 2nd contrast
contrast2 <- makeContrasts(Day14.P-Day14.NP, levels=design)
fit2 <- contrasts.fit(fit, contrast2)
final.fit2 <- eBayes(fit2)
top2 <- topTableF(final.fit2, adjust.method="BH", n=nrow(mat),sort.by="none")

#Prepare matrix of p-values
pvals.study1 <- cbind(top1$P.Value, top2$P.Value)
colnames(pvals.study1) <- c("Day12.P-Day12.NP","Day14.P-Day14.NP")
rownames(pvals.study1)<- rownames(top1)

#############################################################################
#Use mvGST annotation methods to build GO gene set list for example study 1
#Analyse this list with mvGST statistical methods
#############################################################################
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#Slightly modify profileTable to not only evaluate the GO gene set list it creates
#but also return it and make it available outside of the function.
profileTable <- function (pvals, gene.names = NULL, contrasts = NULL, list.groups
= NULL,
sig.level = 0.05, gene.ID, organism, affy.chip, ontology = "BP",
method = 2, minsize = 1, maxsize = Inf, mult.adj = "BY")
{
if (is.null(contrasts)) {
contrasts <- colnames(pvals)
}
if (is.null(gene.names)) {
gene.names <- rownames(pvals)
}
if (!is.matrix(pvals)) {
stop("pvals must be a matrix")
}
if (!is.element(mult.adj, c("BY", "SFL"))) {
stop("mult.adj must be one of ’BY’ or ’SFL’")
}
vars <- length(unlist(strsplit(contrasts[1], "[.]")))
if (vars == 1) {
contrasts <- paste(contrasts, ontology, sep = ".")
}
f.one <- 1 - .Machine$double.eps
f.zero <- .Machine$double.eps
pvals <- ifelse(pvals == 1, f.one, pvals)
pvals <- ifelse(pvals == 0, f.zero, pvals)
if (is.null(list.groups)) {
if (any(gene.ID == c("affy", "genbank", "alias", "ensembl",
"entrez", "symbol", "genename", "unigene")) != TRUE) {
old.names <- character()
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new.names <- character()
for (i in seq.int(from = 0, to = floor(length(gene.names)/1000))) {
low <- i * 1000 + 1
high <- (i + 1) * 1000
if (high > length(gene.names)) {
high <- length(gene.names)
}
gene.names <- toupper(gene.names)
converted1 <- gconvert(gene.names[low:high],
target = "ENTREZGENE_ACC", organism = organism)
old.names <- c(old.names, as.character(converted1$alias))
new.names <- c(new.names, as.character(converted1$target))
}
if (grep("^[[:digit:]]+$", str_trim(gene.names[1])) ==
1) {
all.numeric <- TRUE
}
new.genes <- cbind(old.names, new.names)
new.genes[, 2] <- gsub("ENTREZGENE_ACC:", "", new.genes[,2])
if (all.numeric) {
new.genes[, 1] <- substr(new.genes[, 1], regexpr("[[:digit:]]+$",
new.genes[, 1]), nchar(new.
genes[, 1]))
}
duplicate <- rep(FALSE, length(new.genes[, 1]))
for (i in seq_along(new.genes[, 1])[-1]) {
duplicate[i] <- ifelse(all(new.genes[i, ] ==
new.genes[i - 1, ]), TRUE, FALSE)
}
new.genes <- new.genes[!duplicate, ]
converted <- geneNameConvertRows(pvals, gene.names,
new.genes, method)
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pvals <- converted$p.mat
gene.names <- converted$genes
gene.ID <- "entrez"
}
list.groups1 <<- generateGeneSets(ontology = ontology,
species = organism, ID = gene.ID, affy.chip)
offspring <- get("as.list", pos = "package:AnnotationDbi")(get(paste("GO",
ontology, "
OFFSPRING",
sep = "")))
list.groups <- sapply(1:length(offspring), function(x) fillInList(list.groups1
[[names(offspring[x])]],
names(offspring)[x
], offspring,
list.groups1))
names(list.groups) <- names(offspring)
size <- sapply(list.groups, length)
list.groups <<- list.groups[(size >= minsize) & (size <=
maxsize)]
}
pmat <- mvGSTObject(gene.names, contrasts, pvals, list.groups)
grouped.pmat <- separate(pmat, list.groups)
if (mult.adj == "SFL") {
adjusted <- grouped.pmat
adjusted$adjusted.group.pvals <- grouped.pmat$grouped.raw
adjusted$adjusted.group.pvals[] <- NA
ncgp <- ncol(grouped.pmat$grouped.raw)
for (i in seq_len(ncgp)) {
pvalues <- grouped.pmat$grouped.raw[, i]
two.sided <- convertPvalues(pvalues, two.sided = FALSE)
names(two.sided) <- grouped.pmat$group.names
new.pvalues <- p.adjust.SFL(two.sided, sig.level = sig.level)
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relative <- ifelse(pvalues < 0.5, 1, -1)
one.combined <- convertPvalues(new.pvalues, relative)
adjusted$adjusted.group.pvals[, i] <- one.combined
}
}
else if (mult.adj == "BY") {
adjusted <- oneSideBYAdjust(grouped.pmat)
}
one.zero <- changeTO10(adjusted, sig.level = sig.level)
almost.final <- finalResults(one.zero)
near.final <- cut(almost.final)
final <- mvSort(near.final)
return(final)
}

#Generate mvGST analysis results and return the GO gene set list used in the
analysis
results.mvGST <- profileTable(pvals.study1, sig.level = 0.05, gene.ID = "affy",
organism = "btaurus",
affy.chip="bovine.db", ontology = "BP", method = 2,
minsize = 1,
maxsize = Inf, mult.adj = "BY")

#Save matrix of p-values to be used latter in mvGST analysis with different GO
gene set lists
#Rename list.groups to identify list was built for Bos taurus with mvGST
annotation methods
#Save the renamed list
save(pvals.study1, file="/Users/russell/Desktop/USU Student Materials/Research
Summer 2014/Thesis/R Code/pvals.study1")
profileTable.btaurus <- list.groups
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save(profileTable.btaurus,file="/Users/russell/Desktop/USU Student Materials/
Research Summer 2014/Thesis/R Code/profileTable.btaurus")

load("/Users/russell/Desktop/USU Student Materials/Research Summer 2014/Thesis/R
Code/pvals.study1")
load("/Users/russell/Desktop/USU Student Materials/Research Summer 2014/Thesis/R
Code/profileTable.btaurus")

##############################################################################
#Create GO gene set list using biomart annotation method for example study 1
#Test the list for DE among GO gene sets using mvGST
##############################################################################
library(biomaRt)
library(dplyr)

#To access archived databases it’s recommended to set the host to the desired
archived Ensembl website
#A list of archived websites can be found at: http://www.ensembl.org/info/website/
archives/index.html
#80 or may2015 is the most recent
ensembl_80 = useMart(biomart="ENSEMBL_MART_ENSEMBL", host="may2015.archive.ensembl
.org",
path="/biomart/martservice")

#View list of datasets available in this biomart version
#listDatasets(ensembl_80)
#Check number of different species are supported in this biomart version
#dim(ensembl_80)

#Qeury Ensembl database for Bos taurus
ensembl_80_btaurus <- useMart(biomart="ENSEMBL_MART_ENSEMBL", host="may2015.
archive.ensembl.org",
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path="/biomart/martservice", dataset="btaurus_gene_
ensembl")

#Databases are large, check dimension first before exploring attributes
#dim(listAttributes(ensembl_80_btaurus))
#See what what attributes are available for Bos taurus
#This argument is where gnc options can be found
#listAttributes(ensembl_80_btaurus)[1:100,]

#Creates data frame of selected items where rows are different annotation mappings
#For example study 1, the microarray is Affymetrix Bovine. "namespace_1003" is GO
domain
#Query takes less than a minuete.
annotation <- getBM(attributes=c(’affy_bovine’, ’go_id’, ’namespace_1003’),
values=T, mart = ensembl_80_btaurus)

#The resulting data frame has missing values. Each column’s missing values either
#are represented by "" or NA but never both. Missing values can be avoided with
specific
#arguments passed to getBM, but subsetting must be done to include on BP GO so it’
s easier
#to just subset out rows with missing values at the same time.

new.annot <- filter(select(annotation, affy_bovine, go_id, go_domain=namespace_
1003),
affy_bovine != "", go_id != "", go_domain == "biological_process
")

#Create GO gene set lists
listBuilder <- function (annotations) {
x <- annotations$go_id
y <- annotations$affy_bovine #specific to the probeIDs or gnc
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uniques <- unique(x)
groupList <- setNames(vector("list", length(unique(x))), uniques)
finish <- length(uniques)
for (i in 1:finish)
{
t <- grep(uniques[i], x)
groupList[[i]] <- y[t]
}

#The hierarchical structure of GO necessitates getting the offspring GO terms
and including them in the list
offspring <- get("as.list", pos = "package:AnnotationDbi")(get(paste("GO", "BP",
"OFFSPRING", sep = "")))
groupList1 <- sapply(1:length(offspring), function(x) fillInList(groupList[[
names(offspring[x])]],
names(offspring)[x],
offspring,
groupList))
names(groupList1) <- names(offspring)
#Only include gene sets with at least one gene
final.list <- groupList1[sapply(groupList1, length)!=0]

return(final.list)
}
#Takes about 4 minutes
ptm <- proc.time()
groupList <- listBuilder(new.annot)
proc.time() - ptm

#Check list for any duplicated probeIDs within each GO gene set
sum(unlist(lapply(groupList, function (x) sum(duplicated(x)))))
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#Save list with name that identifys some of the list’s attributes and also so you
#don’t have to create the list until a new version of biomart is released
biomart.btaurus <- groupList
save(biomart.btaurus,file="/Users/russell/Desktop/USU Student Materials/Research
Summer 2014/Thesis/R Code/biomart.btaurus")

load("/Users/russell/Desktop/USU Student Materials/Research Summer 2014/Thesis/R
Code/biomart.btaurus")
results.biomart <- profileTable(pvals.study1, list.groups=biomart.btaurus, sig.
level = 0.05, mult.adj = "BY")

##########################################################################
#Create GO gene set list using affy annotation method for example study 1
#Test the list for DE among GO gene sets using mvGST
##########################################################################

#This file was downloaded on May 26 2015 from the Affymetrix website
#found here: http://www.affymetrix.com/support/technical/annotationfilesmain.affx
annot <- read.csv(file="/Users/russell/Desktop/USU Student Materials/Research
Summer 2014/Data/Bovine/Bovine.na35.annot.csv",head=TRUE,sep=",", skip=19)

sub <- as.matrix(select(annot,
probe_id = Probe.Set.ID,
go_id_bp = Gene.Ontology.Biological.Process))

#Get go_id terms out of column gene.onotology.biological.process with regular
expression
go_id <- list()
finish <- length(sub[,2])
for (i in 1:finish) {
go_id[[i]] <- unlist(strsplit(as.character(sub[,2][i]), "[^0-9]+"))
}
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#Build GO terms gene set list
#Takes over an hour
gene.set.list <- setNames(vector("list", sum(nchar(unique(unlist(go_id)))==7)),
unique(unlist(go_id))[nchar(unique(unlist(go_id)))==7])
finish <- length(gene.set.list)
for (i in 1:finish) {
t <- grep(names(gene.set.list[i]), go_id)
gene.set.list[[i]] <- sub[t,1]
}
names(gene.set.list) <- paste0("GO:", names(gene.set.list))

#The hierarchical structure of GO necessitates getting the offspring GO terms and
including them in the list
offspring <- get("as.list", pos = "package:AnnotationDbi")(get(paste("GO", "BP", "
OFFSPRING", sep = "")))
full.gene.set.list <- sapply(1:length(offspring), function(x) fillInList(gene.set.
list[[names(offspring[x])]],
names(offspring)
[x],
offspring,
gene.set.list
))
names(full.gene.set.list) <- names(offspring)

#Only include gene sets with at least one gene
final.list <- full.gene.set.list[sapply(full.gene.set.list, length)!=0]

#Check list for any duplicated probeIDs within each GO gene set
sum(unlist(lapply(final.list, function (x) sum(duplicated(x)))))

#Save list with meaningful name
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#Saving this list is important because it takes over an hour to create!!
affy.btaurus <- final.list
save(affy.btaurus,file="/Users/russell/Desktop/USU Student Materials/Research
Summer 2014/Thesis/R Code/affy.btaurus")

load("/Users/russell/Desktop/USU Student Materials/Research Summer 2014/Thesis/R
Code/affy.btaurus")
results.affy <- profileTable(pvals.study1, list.groups=affy.btaurus, sig.level =
0.05, mult.adj = "BY")

library(GEOquery)
library(mvGST)
library(GO.db)
library(gProfileR)
library(biomaRt)
library(Biostrings)
library(microbenchmark)
library(matchingMarkets)
library(limma)
library(dplyr)

#select() is masked by the following packages: biomaRt, AnnotationDbi, MASS
#move select() from dplyr to gobal environment so it’s always called first.
select <- dplyr:::select

##########################################################################

#Annotation for Agilent-019921 Microarray

#Agilent annotation file downloaded from website: https://earray.chem.agilent.com/
earray/
#on Monday, November 10, 2014 at 11:39 AM
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#Researcher Group’s annotation obtained through Gene Expression Omnibus: GPL14112
##########################################################################

#Read in data downloaded from Agilent Website
agilent <- read.delim("/Users/russell/Desktop/USU Student Materials/Research
Summer 2014/Data/AllAnnotations\\019921_D_AA_20141001.txt"
, stringsAsFactors=F, fill=TRUE, sep=)
#Read in data from Gene Expression Omnibus
research <- Table(getGEO("GPL14112", GSEMatrix=TRUE))

#Some functions to be used later
quickView <- function (data) {
#Function to Get General Info about Annotation from Sources
#Function takes data frame as input
#Make sure all missing data is "" not NAs
data[is.na(data)] <- ""
overview <- matrix(ncol=6)
for (i in 1:length(colnames(data))) {
colVec <- data[,i]
rows <- length(colVec)
annotated <- length(colVec[colVec !=""])
duplicates <- sum(duplicated(colVec[colVec !=""]) | duplicated(colVec[colVec !
=""], fromLast=TRUE))
uniques <- annotated-duplicates
p.annot <- round(annotated/rows,2)
p.un.annot <- round(uniques/rows,2)
p.annot.dup <- round((annotated-uniques)/annotated,2)
overview <- rbind(overview, c(rows,annotated,p.annot, uniques, p.un.annot, p.
annot.dup))
}
overview <- overview[-1,]
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row.names(overview) <- colnames(data)
colnames(overview) <- c("rows","rows w\annot.","% rows w\annot.","rows w\nd.
annot.","% rows w\nd.annot.","% annot. duplicated")
overview
}
gncTranslate <- function (bimapLeft, bimapRight, gnc.translator, all.probe.ids) {
#Function to merge two bimaps and give info about the merge
#Make sure there are no missing entries ("" or NA) in either bimap
#Make sure merger is a character column name common to both bimaps (gnc to use
as translator)

merged <- distinct(merge(bimapLeft, bimapRight, gnc.translator))
colnames(merged) <- c(’gnc’,’probe_id’,’go_id’,’go_domain’)

#Microarray chip coverage as intersection of unique probe_ids after merge over
all unique probe_ids
common <- intersect(unique(all.probe.ids), unique(merged$probe_id))
chipC <- length(common)/length(unique(all.probe.ids))

sets <- length(unique(merged$go_id))
gncs <- length(unique(merged$gnc))
probes <- length(unique(merged$probe_id))
annotations <- distinct(select(merged, gnc, probe_id))
annots <- dim(annotations)[1]

myList <- list()
myList[[1]] <- merged
myList[[2]] <- annotations
myList[[3]] <- data.frame("GOgncs"=gncs, "probeIDs"=probes, "Annotations"=annots
,
"GO IDs"=sets, "chipCoveragePotential"=chipC)
names(myList) <- c("groupBuilder", "annotations", "performance")
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myList
}
groupBuilder <- function (groupBuilder) {
x <- groupBuilder$go_id
y <- groupBuilder[,c("gnc","probe_id")]
uniques <- unique(x)
groupList <- setNames(vector("list", length(unique(x))), uniques)
finish <- length(uniques)
for (i in 1:finish)
{
t <- grep(uniques[i], x)
groupList[[i]] <- y[t,]
}
groupList
}
alignments <- function (gnc.seqs, probe.seqs, annotations, gnc, probe_id) {

mergedSeqs <- merge(merge(annotations, gnc.seqs, by=gnc), probe.seqs, by=probe_
id)

typeChoice <- c("global", "local", "overlap", "global-local","local-global")
submat <- nucleotideSubstitutionMatrix(match = 0, mismatch = -1, baseOnly =
FALSE)
mergedSeqs <- data.frame(mergedSeqs,"align_score"=NA)
finish <- dim(mergedSeqs)[1]
for (i in 1:finish) {
mergedSeqs[i, 5] <- pairwiseAlignment(pattern = mergedSeqs$gnc.seq[i], subject
= mergedSeqs$probe_id.seq[i],
substitutionMatrix = submat, gapOpening = 0,
gapExtension = 1,
scoreOnly = TRUE, type=typeChoice[4])
}
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mergedSeqs[,c(’probe_id’,’gnc’,’align_score’)]
}
annotator <- function(m) {
data.frame(m, "annotations"=apply(m, 1, function(x) paste(x[1],x[2], sep="<MAP>"
)))
}
smp <- function (groupList.annot, m.annot) {
#Each element in groupsList.annot should have three columns "gnc","probe_id","
annotations"
#m.annot should have four columns named "gnc","probe_id","align_score","
annotations"
groups <- list()
finish <- length(names(groupList.annot))
for (k in 1:finish) {
groups[[k]] <- data.frame(groupList.annot[[k]], "score"=NA)
finish1 <- dim(groups[[k]])[1]
for (i in 1:finish1) {
t <- grep(groups[[k]]$annotations[i], m.annot$annotations, fixed=TRUE)
groups[[k]]$score[i] <- max(m.annot$align_score[t])
}
}

#order each gnc type by score
gnc.ordered.groups <- list()
probes.ordered.groups <- list()
for (i in 1:finish) {
gnc.ordered.groups[[i]] <- groups[[i]][order(groups[[i]]$gnc, groups[[i]]$
score, decreasing=T),]
probes.ordered.groups[[i]] <- groups[[i]][order(groups[[i]]$probe_id, groups[[
i]]$score, decreasing=T),]
}
length(gnc.ordered.groups)
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length(probes.ordered.groups)
gnc.ordered.groups[20]
probes.ordered.groups[20]

list.groups <- list()
for(i in 1:finish) {
n.pro <- length(unique(gnc.ordered.groups[[i]]$probe_id))
n.gnc <- length(unique(gnc.ordered.groups[[i]]$gnc))
u.pro <- unique(gnc.ordered.groups[[i]]$probe_id)
u.gnc <- unique(gnc.ordered.groups[[i]]$gnc)
gnc.ordered <- gnc.ordered.groups[[i]]$gnc
probes.ordered <- probes.ordered.groups[[i]]$probe_id

if (n.pro > 1 & n.gnc > 1) {
gnc.prefs <- vector(,n.pro)
for (k in 1:n.gnc) {
t <- grep(u.gnc[k], gnc.ordered)
gnc.prefs <- cbind( gnc.prefs, c(t, rep(NA,n.pro-length(t))) )
}
gnc.prefs <- gnc.prefs[,-1]

probe.prefs <- vector(,n.gnc)
for (a in 1:n.pro) {
t <- grep(u.pro[a], probes.ordered)
probe.prefs <- cbind( probe.prefs, c(t, rep(NA,n.gnc-length(t))) )
}
probe.prefs <- probe.prefs[,-1]

result <- daa(s.prefs=gnc.prefs, c.prefs=probe.prefs)$match.mat
colnames(result) <- u.pro
list.groups[[i]] <- rownames(which(t(result)==TRUE, arr.ind = TRUE))
} else {
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list.groups[[i]] <- as.vector(gnc.ordered.groups[[i]]$probe_id)
}
}
list.groups
}

################################################################
#####SELECT GENE NAMING CONVENTION (GNC) TO USE AS TRANSLATOR
#Get overview info about annotation to find and select ’sensible’ gnc-translator
candidates.
################################################################
quickView(agilent)
quickView(research)

######################################################
#GenbankAccession as gnc-translator (source:agilent)
######################################################
#Select version of biomart (see biomart website for list of available archives)
#host="may20015 portion corresponds to ensembl version 80 (current version)
#Select organism with dataset="" option. To see possible choices use:
#listDatasets(ensembl_80)
ensembl_80_oaries <- useMart(biomart="ENSEMBL_MART_ENSEMBL", host="may2015.archive
.ensembl.org",
path="/biomart/martservice", dataset="oaries_gene_
ensembl")

#Query biomart to get gnc-go bimap
#dim(listAttributes(ensembl_80_oaries))
#listAttributes(ensembl_80_oaries)[1:100,]
#listFilters(ensembl_80_oaries)
embl.go <- getBM(attributes=c(’embl’, ’go_id’, ’namespace_1003’),
filters="with_go_id", values=TRUE, mart = ensembl_80_oaries)
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embl.go <- filter(embl.go, embl != "", go_id != "", namespace_1003 != "",
namespace_1003=="biological_process")

#Get from source probeID-gnc bimap
#Make sure that gnc translator has common character name in both bimaps
probe.embl <- filter(select(agilent, ProbeID, GenbankAccession), ProbeID != "",
GenbankAccession != "")
probe.embl <- select(probe.embl, ProbeID, embl=GenbankAccession)

#Use gncTranslate function to estimate gnc-translator quality
#Larger numbers in GO.IDs and chipCoveragePotential is better.
agilent.gnc.GB_ACC <- gncTranslate(probe.embl,embl.go,"embl",agilent$ProbeID)
#names(agilent.gnc.GB_ACC)
#head(agilent.gnc.GB_ACC$groupBuilder)
#head(agilent.gnc.GB_ACC$annotations)
agilent.gnc.GB_ACC$performance

############################################
#Unigene as gnc-translator (source:agilent)
############################################
#Query biomart to get gnc-go bimap
#dim(listAttributes(ensembl_80_oaries))
#listAttributes(ensembl_80_oaries)[1:100,]
#listFilters(ensembl_80_oaries)
unigene.go <- getBM(attributes=c(’unigene’, ’go_id’, ’namespace_1003’),
filters="with_unigene", values=TRUE, mart = ensembl_80_oaries)
#Include distinct rows of row combined queries then filter rows to specified
domain and get rid of missings
unigene.go <- filter(unigene.go, unigene != "", go_id != "", namespace_1003 != "",
namespace_1003=="biological_process")

#Get from source probeID-gnc bimap
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#Make sure that gnc translator has common character name in both bimaps
probe.unigene <- filter(select(agilent, ProbeID, UniGeneID), ProbeID != "",
UniGeneID != "")
probe.unigene <- select(probe.unigene, ProbeID, unigene=UniGeneID)

#Use gncTranslate function to estimate gnc-translator quality
#Larger numbers in GO.IDs and chipCoveragePotential is better.
agilent.gnc.unigene <- gncTranslate(probe.unigene,unigene.go,"unigene",agilent$
ProbeID)
#names(agilent.gnc.unigene)
#head(agilent.gnc.unigene$groupBuilder)
#head(agilent.gnc.unigene$annotations)
agilent.gnc.unigene$performance

############################################
#Entrez as gnc-translator (source:agilent)
############################################
#Query biomart to get gnc-go bimap
#dim(listAttributes(ensembl_80_oaries))
#listAttributes(ensembl_80_oaries)[1:100,]
#listFilters(ensembl_80_oaries)
entrez.go <- getBM(attributes=c(’entrezgene’, ’go_id’, ’namespace_1003’),
filters="with_entrezgene", values=TRUE, mart = ensembl_80_oaries)
#Include distinct rows of row combined queries then filter rows to specified
domain and get rid of missings
entrez.go <- filter(entrez.go, entrezgene != "", go_id != "", namespace_1003 != ""
, namespace_1003=="biological_process")

#Get from source probeID-gnc bimap
#Make sure that gnc translator has common character name in both bimaps
agilent$EntrezGeneID[is.na(agilent$EntrezGeneID)] <- "" #Careful with entrez in
agilent. Missing data are NAs not "".
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probe.entrez <- filter(select(agilent, ProbeID, EntrezGeneID), ProbeID != "",
EntrezGeneID != "")
#Make sure that gnc translator has common character name in both bimaps
probe.entrez <- select(probe.entrez, ProbeID, entrezgene=EntrezGeneID)

#Use gncTranslate function to estimate gnc-translator quality
#Larger numbers in GO.IDs and chipCoveragePotential is better.
agilent.gnc.entrez <- gncTranslate(probe.entrez,entrez.go,"entrezgene", agilent$
ProbeID)
#names(agilent.gnc.entrez)
#head(agilent.gnc.entrez$groupBuilder)
#head(agilent.gnc.entrez$annotations)
agilent.gnc.entrez$performance

###############################################################
#RefSeq as gnc-translator (source:agilent)
#This is an example of multiple types of gncs being classified as one by a
manufactuerer.
#Agilent has refseq as one gnc but biomart has three for refseq.
#To handle this issue, multiple queries to biomart can be made to increase
annotation
#coverage.
###############################################################
#Query biomart to get gnc-go bimap
#dim(listAttributes(ensembl_80_oaries))
#listAttributes(ensembl_80_oaries)[1:100,]
#listFilters(ensembl_80_oaries)
refseq_mrna.go <- getBM(attributes=c(’refseq_mrna’, ’go_id’, ’namespace_1003’),
values=TRUE, mart = ensembl_80_oaries)
refseq_mrna_predicted.go <- getBM(attributes=c(’refseq_mrna_predicted’, ’go_id’, ’
namespace_1003’),
values=TRUE, mart = ensembl_80_oaries)
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refseq_ncrna_predicted.go <- getBM(attributes=c(’refseq_ncrna_predicted’, ’go_id’,
’namespace_1003’),
values=TRUE, mart = ensembl_80_oaries)
#Make the multiple biomart queries one
colnames(refseq_mrna.go) <- c("refseq",’go_id’,’namespace_1003’)
colnames(refseq_mrna_predicted.go) <- c("refseq",’go_id’,’namespace_1003’)
colnames(refseq_ncrna_predicted.go) <- c("refseq",’go_id’,’namespace_1003’)
#Include distinct rows of row combined queries then filter rows to specified
domain and get rid of missing
refseq.go <- distinct(rbind(refseq_mrna.go,refseq_mrna_predicted.go,refseq_ncrna_
predicted.go))
refseq.go <- filter(refseq.go, refseq != "", go_id != "", namespace_1003 != "",
namespace_1003=="biological_process")

#Get from source probeID-gnc bimap
#Make sure that gnc translator has common character name in both bimaps
probe.refseq <- filter(select(agilent, ProbeID, RefSeqAccession), ProbeID != "",
RefSeqAccession != "")
probe.refseq <- select(probe.refseq, ProbeID, refseq=RefSeqAccession)

#Use gncTranslate function to estimate gnc-translator quality
#Larger numbers in GO.IDs and chipCoveragePotential is better.
agilent.gnc.refseq <- gncTranslate(probe.refseq,refseq.go,"refseq", agilent$
ProbeID)
#names(agilent.gnc.refseq)
#head(agilent.gnc.refseq$groupBuilder)
#head(agilent.gnc.refseq$annotations)
agilent.gnc.refseq$performance

###############################################################################
#The research file has a gnc titled ’Primary Accession. This gnc actually is
#a composite of other gncs in the file, many of which are GB_ACCs.
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#GB_ACC as gnc-translator (source:research)
###############################################################################
#Query biomart to get gnc-go bimap has alread been done for emble (genbank) ID

#Get from source probeID-gnc bimap
#Make sure that gnc translator has common character name in both bimaps
probe.embl <- filter(select(research, ID, GB_ACC), ID != "", GB_ACC != "")
probe.embl <- select(probe.embl, ID, embl=GB_ACC)

#Use gncTranslate function to estimate gnc-translator quality
#Larger numbers in GO.IDs and chipCoveragePotential is better.
research.gnc.embl <- gncTranslate(probe.embl,embl.go,"embl", research$ID)
#names(research.gnc.embl)
#head(research.gnc.embl$groupBuilder)
#head(research.gnc.embl$annotations)
research.gnc.embl$performance

############################################
#ORF as gnc-translator (source:research)
#ORF is not a gnc, but ORF contains majority
#HGNC symbols gnc and this was used.
############################################
#Query biomart to get gnc-go bimap
#dim(listAttributes(ensembl_80_oaries))
#listAttributes(ensembl_80_oaries)[1:100,]
#listFilters(ensembl_80_oaries)
hgnc_symbol.go <- getBM(attributes=c(’hgnc_symbol’, ’go_id’, ’namespace_1003’),
values=TRUE, mart = ensembl_80_oaries)
#Include distinct rows of row combined queries then filter rows to specified
domain and get rid of missings
hgnc_symbol.go <- filter(hgnc_symbol.go, hgnc_symbol != "", go_id != "", namespace
_1003 != "", namespace_1003=="biological_process")
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#Get from source probeID-gnc bimap
#Make sure that gnc translator has common character name in both bimaps
probe.hgnc_symbol <- filter(select(research, ID, ORF), ID != "", ORF != "")
probe.hgnc_symbol <- select(probe.hgnc_symbol, ID, hgnc_symbol=ORF)

#Use gncTranslate function to estimate gnc-translator quality
#Larger numbers in GO.IDs and chipCoveragePotential is better.
agilent.hgnc_symbol <- gncTranslate(probe.hgnc_symbol,hgnc_symbol.go,"hgnc_symbol"
,research$ID)
#names(agilent.hgnc_symbol)
#head(agilent.hgnc_symbol$groupBuilder)
#head(agilent.hgnc_symbol$annotations)
agilent.hgnc_symbol$performance

######################################################################
#Take best gnc-translator use SMP procedure to build GO Gene Set List
######################################################################

#Local-Global Alignments to rank annotations within each unique go term
#First guild gene group sets
#Takes about 3-4 min.
groupList <- groupBuilder(agilent.hgnc_symbol$groupBuilder)

#Get Sequences for unique gnc and unique prob with biomart query
#Takes about 2-3 min.
gnc.seqs <- getBM(attributes=c(’cdna’,’hgnc_symbol’),
filters="hgnc_symbol", values=unique(agilent.hgnc_symbol$
annotations$gnc),
mart = ensembl_80_oaries)
probe.seqs <- read.delim("/Users/russell/Desktop/USU Student Materials/Research
Summer 2014/Data/SequenceList\\019921_D_SequenceList_20141001.txt"
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, stringsAsFactors=F, fill=TRUE, sep=)

#Change column names appropriately (probe identifier and gnc columns should have
same names across bimaps)
colnames(gnc.seqs) <- c("gnc.seq","gnc")
colnames(probe.seqs) <- c("probe_id","probe_id.seq")
colnames(agilent.hgnc_symbol$annotations) <- c("gnc","probe_id")

#Sequence alignments for each unique combination of probe and gnc seqs.
#Some annotations will have different combinations of probe and gnc seqs, but
#they are few and this will be handled later in the smp function by picking the
#max alignment score for duplicate annotations.
#Sequences are used to get align_scores, but are not returned.
#Takes about 3-4 min.
agilent.hgnc_symbol.alignments <- alignments(gnc.seqs, probe.seqs, agilent.hgnc_
symbol$annotations,
colnames(agilent.hgnc_symbol$annotations)[1], colnames(agilent.hgnc_
symbol$annotations)[2])
#dim(agilent.hgnc_symbol.alignments)

#Matrix of containing bimap where rows are annotations with align_scores for each
row
#Be sure to put columns in appropriate order to match annotations in groupList
#(returned by groupBuilder.)
m <- agilent.hgnc_symbol.alignments[,c("gnc", "probe_id", "align_score")]

#The annotator function provides one annotation for each row (through paste
function) and
#will help with computation time when matching later.
m.annot <- annotator(m)
groupList.annot <- lapply(groupList, annotator)
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#Function to grab preferences, rank them for each element and use them in
#Gale-Shapley’s Deferred Acceptance Algorithm (daa) also known as the stable
#marriage algorithm for the stable marriage problem (smp).
#Takes about #4-5 min.
list.groups <- smp(groupList.annot, m.annot)
#list.groups[1:10]

list.groups.oaries <- list.groups
#Put GO Terms back as names of list
names(list.groups.oaries) <- names(groupList)

#The hierarchical structure of GO necessitates getting the offspring GO terms and
including them in the list
offspring <- get("as.list", pos = "package:AnnotationDbi")(get(paste("GO", "BP", "
OFFSPRING", sep = "")))
full.list.groups.oaries <- sapply(1:length(offspring), function(x) fillInList(list
.groups.oaries[[names(offspring[x])]],
names(offspring)
[x],
offspring,
list.groups.
oaries))
names(full.list.groups.oaries) <- names(offspring)

#Only include gene sets with at least one gene
final.list.groups.oaries <- full.list.groups.oaries[sapply(full.list.groups.oaries
, length)!=0]

#Check list for any duplicated probeIDs within each GO gene set
sum(unlist(lapply(final.list.groups.oaries, function (x) sum(duplicated(x)))))

#Save with meaningful name.
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#Total procedure takes less than 15 min.
save(final.list.groups.oaries, file="/Users/russell/Desktop/USU Student Materials/
Research Summer 2014/Thesis/R Code/final.list.groups.oaries")
load("/Users/russell/Desktop/USU Student Materials/Research Summer 2014/Thesis/R
Code/final.list.groups.oaries")

####################
#mvGST Analysis
####################
#Get the expression data#
EsetGSE52888 <- getGEO("GSE52888",GSEMatrix=TRUE)
#It reads in as a list of length one. Point to the ExpressionSet and save as an
object
#so that it can be used in the global environment.
EsetGSE52888 <- EsetGSE52888$GSE52888_series_matrix.txt.gz

#Get probeIDs associated with GSE52888
probe.ids <- getGEO("GPL10427",GSEMatrix=FALSE)
probe.ids <- Table(probe.ids)[,8]
probe.ids <- as.character(probe.ids)

#Some functions used to explore an expression set object
#class(EsetGSE52888)
# featureNames(EsetGSE52888)[1:5]
# fvarLabels(EsetGSE52888)
#sampleNames(EsetGSE52888)
#varLabels(EsetGSE52888)

##################################################################
#Limma\eBayes to test DE among genes across contrasts of interest
#Results in a matrix of p-values
##################################################################
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#Extract matrix of expression values
mat <- exprs(EsetGSE52888)
#Name columns appropriately where each column identifys a particular sample
#C:Control
#BO:Brachiocephalic Occlusion
#EBO:Estradiol Plus Brachiocephalic Occlusion
#E:Estradiol
colnames(mat) <- c("C","C","C","C",
"BO","BO","BO","BO",
"EBO","EBO","EBO","EBO",
"E","E","E","E")
#Define treatments, fit linear model
Treatment <- as.factor(c("C","C","C","C","BO","BO","BO","BO",
"EBO","EBO","EBO","EBO","E","E","E","E"))
#Define design matrix
design <- model.matrix(~0+Treatment)
colnames(design) <- c(’C’,’BO’,’EBO’,’E’)
#Fit linear model
fit <- lmFit(mat, design)

#Test 1st contrast
contrast1 <- makeContrasts(BO-C, levels=design)
fit1 <- contrasts.fit(fit, contrast1)
final.fit1 <- eBayes(fit1)
top1 <- topTableF(final.fit1, adjust.method="BH", n=nrow(mat), sort.by="none")

#Test 2nd contrast
contrast2 <- makeContrasts(EBO-C, levels=design)
fit2 <- contrasts.fit(fit, contrast2)
final.fit2 <- eBayes(fit2)
top2 <- topTableF(final.fit2, adjust.method="BH", n=nrow(mat),sort.by="none")
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#Test 3rd contrast
contrast3 <- makeContrasts(E-C, levels=design)
fit3 <- contrasts.fit(fit, contrast3)
final.fit3 <- eBayes(fit3)
top3 <- topTableF(final.fit3, adjust.method="BH", n=nrow(mat),sort.by="none")

#Prepare matrix of p-values
pvals.study2 <- cbind(top1$P.Value, top2$P.Value, top3$P.Value)
colnames(pvals.study2) <- c("BO-C","EBO-C","E-C")
rownames(pvals.study2)<- probe.ids

head(pvals.study2)

save(pvals.study2, file="/Users/russell/Desktop/USU Student Materials/Research
Summer 2014/Thesis/R Code/pvals.study2")

######################
#Study 1 Comparisons
######################
library(graphics)
library(Hmisc)
library(mvGST)
library(dplyr)

my.colors <- c("#66c2a5", "#fc8d62", "#8da0cb")

load("/Users/russell/Desktop/USU Student Materials/Research Summer 2014/Thesis/R
Code/profileTable.btaurus")
load("/Users/russell/Desktop/USU Student Materials/Research Summer 2014/Thesis/R
Code/biomart.btaurus")
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load("/Users/russell/Desktop/USU Student Materials/Research Summer 2014/Thesis/R
Code/affy.btaurus")
load("/Users/russell/Desktop/USU Student Materials/Research Summer 2014/Thesis/R
Code/pvals.study1")

annot <- read.csv(file="/Users/russell/Desktop/USU Student Materials/Research
Summer 2014/Data/Bovine/Bovine.na35.annot.csv",head=TRUE,sep=",", skip=19)
total.probes <- length(unique(annot$Probe.Set.ID))

#Unique GO identifiers in each list
y <- list()
y[[1]] <- unique(names(biomart.btaurus))
y[[2]] <- unique(names(affy.btaurus))
y[[3]] <- unique(names(profileTable.btaurus))

#Unique genes in each list
x <- list()
x[[1]] <- unique(unlist(biomart.btaurus))
x[[2]] <- unique(unlist(affy.btaurus))
x[[3]] <- unique(unlist(profileTable.btaurus))

#Unique GO gene sets
w <- list()
w[[1]] <- unique(biomart.btaurus)
w[[2]] <- unique(affy.btaurus)
w[[3]] <- unique(profileTable.btaurus)

##########################
#Compare list performace
##########################
pdf("/Users/russell/Desktop/USU Student Materials/Research Summer 2014/Thesis/
figures/listPerformancePlot.pdf")

78
plot(y=sapply(y, length), x=sapply(x, length)/total.probes, pch=c(21,22,23),
bg=my.colors, xlab="CHIP COVERAGE", ylab="UNIQUE GO IDS", cex=2)
legend(0.42, 9400, c("Biomart", "Affymetrix", "mvGST"), pt.bg=my.colors,
pch=c(21,22,23), bty="n", cex=1.2, pt.cex=2)
dev.off()

#############################
#Compare lists to each other
#############################

#GO Term Identifiers
ycomp <- vector()
ycomp[1] <- length(intersect(y[[1]], y[[2]]))
ycomp[2] <- length(unique(setdiff(union(y[[1]], y[[2]]), intersect(y[[1]], y[[2]])
)))
ycomp[3] <- length(intersect(y[[1]], y[[3]]))
ycomp[4] <- length(unique(setdiff(union(y[[1]], y[[3]]), intersect(y[[1]], y[[3]])
)))
ycomp[5] <- length(intersect(y[[2]], y[[3]]))
ycomp[6] <- length(unique(setdiff(union(y[[2]], y[[3]]), intersect(y[[2]], y[[3]])
)))
ycomp[7] <- length(intersect(intersect(y[[1]], y[[2]]), y[[3]]))
ycomp[8] <- length(unique(setdiff(union(y[[1]], y[[2]]), y[[3]]),
intersect(intersect(y[[1]], y[[2]]), y[[3]])))

y.inters <- c(ycomp[1],ycomp[3],ycomp[5],ycomp[7])
y.not.inters <- c(ycomp[2],ycomp[4],ycomp[6],ycomp[8])
y.percent.shared <- y.inters/(y.inters+y.not.inters)

#Unique Gene Identifiers
xcomp <- vector()
xcomp[1] <- length(intersect(x[[1]], x[[2]]))
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xcomp[2] <- length(unique(setdiff(union(x[[1]], x[[2]]), intersect(x[[1]], x[[2]])
)))
xcomp[3] <- length(intersect(x[[1]], x[[3]]))
xcomp[4] <- length(unique(setdiff(union(x[[1]], x[[3]]), intersect(x[[1]], x[[3]])
)))
xcomp[5] <- length(intersect(x[[2]], x[[3]]))
xcomp[6] <- length(unique(setdiff(union(x[[2]], x[[3]]), intersect(x[[2]], x[[3]])
)))
xcomp[7] <- length(intersect(intersect(x[[1]], x[[2]]), x[[3]]))
xcomp[8] <- length(unique(setdiff(union(x[[1]], x[[2]]), x[[3]]),
intersect(intersect(x[[1]], x[[2]]), x[[3]])))

x.inters <- c(xcomp[1],xcomp[3],xcomp[5],xcomp[7])
x.not.inters <- c(xcomp[2],xcomp[4],xcomp[6],xcomp[8])
x.percent.shared <- x.inters/(x.inters+x.not.inters)

#GO Gene Sets
#Takes approx. to run, best to save results
wcomp <- vector()
wcomp[1] <- length(intersect(w[[1]], w[[2]]))
wcomp[2] <- length(unique(setdiff(union(w[[1]], w[[2]]), intersect(w[[1]], w[[2]])
)))
wcomp[3] <- length(intersect(w[[1]], w[[3]]))
wcomp[4] <- length(unique(setdiff(union(w[[1]], w[[3]]), intersect(w[[1]], w[[3]])
)))
wcomp[5] <- length(intersect(w[[2]], w[[3]]))
wcomp[6] <- length(unique(setdiff(union(w[[2]], w[[3]]), intersect(w[[2]], w[[3]])
)))
wcomp[7] <- length(intersect(intersect(w[[1]], w[[2]]), w[[3]]))
wcomp[8] <- length(unique(setdiff(union(w[[1]], w[[2]]), w[[3]]),
intersect(intersect(w[[1]], w[[2]]), w[[3]])))
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save(wcomp, file="/Users/russell/Desktop/USU Student Materials/Research Summer
2014/Thesis/R Code/wcomp")
load("/Users/russell/Desktop/USU Student Materials/Research Summer 2014/Thesis/R
Code/wcomp")

w.inters <- c(wcomp[1],wcomp[3],wcomp[5],wcomp[7])
w.not.inters <- c(wcomp[2],wcomp[4],wcomp[6],wcomp[8])
w.percent.shared <- w.inters/(w.inters+w.not.inters)

concordance <- cbind(y.percent.shared,x.percent.shared, w.percent.shared)
colnames(concordance) <- c("GOID","GeneID","GeneSets")
concordance <- arrange(as.data.frame(concordance), desc(GOID))

pdf("/Users/russell/Desktop/USU Student Materials/Research Summer 2014/Thesis/
figures/listConcord.pdf")
dotchart2(concordance[,"GOID"], labels= c("Biomart

\nAffy

"Affy

\nmvGST ",

"Biomart

\nmvGST ",

"Biomart

\nAffy

",

\nmvGST "),

pch=21, xlim=c(0,1), dotsize=1.2,
bg=rep(my.colors[1],4), xaxis=FALSE, cex.lab=1.5)
axis(side = 1, at = c(0,.25,.50,.75,1), labels=c("0",".25",".50",".75","1"),
line=0.5)
title(xlab="Proportion Concordant", line=3, cex=1)
dotchart2(concordance[,"GeneID"], pch=22, dotsize=1.2, add=TRUE,
bg=rep(my.colors[2],4))
dotchart2(concordance[,"GeneSets"], pch=23, dotsize=1.2, add=TRUE,
bg=rep(my.colors[3],4))
legend(.08, 1.5, legend=c("GO IDs", "Gene IDs", "Gene Sets"),
pt.bg=my.colors, pch=c(21,22,23), bty="n", cex=0.8, pt.cex=1)
dev.off()
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########################
#Compare mvGST Results
########################
results <- list()
results[[1]] <- profileTable(pvals=pvals.study1, list.groups=profileTable.btaurus)
results[[2]] <- profileTable(pvals=pvals.study1, list.groups=affy.btaurus)
results[[3]] <- profileTable(pvals=pvals.study1, list.groups=biomart.btaurus)

#Day 12
p.n.12 <- cbind(results[[1]]$results.table[,"P-Day12.NP"],
results[[2]]$results.table[,"P-Day12.NP"],
results[[3]]$results.table[,"P-Day12.NP"])
percent.pn12 <- cbind(p.n.12[,1]/sum(p.n.12[,1]),
p.n.12[,2]/sum(p.n.12[,2]),
p.n.12[,3]/sum(p.n.12[,3]))
percent.pn12
pdf("/Users/russell/Desktop/USU Student Materials/Research Summer 2014/Thesis/
figures/resultsDay12.pdf")
dotchart2(percent.pn12[1,], labels= c("mvGST",
"Affy",
"Biomart"),
pch=21, xlim=c(0,1), dotsize=1.2,
bg=rep(my.colors[1],4), xaxis=FALSE)
axis(side = 1, at = c(0,.25,.5,.75,1),
labels=c("0",".25",".5",".75","1"),
line=0.5)
title(xlab="Proportion of GO Gene Sets", line=3, cex=1)
dotchart2(percent.pn12[2,], pch=22, dotsize=1.2, add=TRUE,
bg=rep(my.colors[2],4))
dotchart2(percent.pn12[3,], pch=23, dotsize=1.2, add=TRUE,
bg=rep(my.colors[3],4))
legend(.1, 1.4, legend=c("Not Significant", "More Active", "Less Active"),
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pt.bg=my.colors, pch=c(21,22,23), bty="n", cex=0.8, pt.cex=1)
dev.off()

#Day 14
p.n.14 <- cbind(results[[1]]$results.table[,"P-Day14.NP"],
results[[2]]$results.table[,"P-Day14.NP"],
results[[3]]$results.table[,"P-Day14.NP"])
percent.pn14 <- cbind(p.n.14[,1]/sum(p.n.14[,1]),
p.n.14[,2]/sum(p.n.14[,2]),
p.n.14[,3]/sum(p.n.14[,3]))
percent.pn14
pdf("/Users/russell/Desktop/USU Student Materials/Research Summer 2014/Thesis/
figures/resultsDay14.pdf")
dotchart2(percent.pn14[1,], labels= c("mvGST",
"Affy",
"Biomart"),
pch=21, xlim=c(0,1), dotsize=1.2,
bg=rep(my.colors[1],4), xaxis=FALSE)
axis(side = 1, at = c(0,.25,.50, .75, 1),
labels=c("0",".25",".50",".75","1"),
line=0.5)
title(xlab="Proportion of GO Gene Sets", line=3, cex=1)
dotchart2(percent.pn14[2,], pch=22, dotsize=1.2, add=TRUE,
bg=rep(my.colors[2],4))
dotchart2(percent.pn14[3,], pch=23, dotsize=1.2, add=TRUE,
bg=rep(my.colors[3],4))
legend(.1, 1.4, legend=c("Not Significant", "More Active", "Less Active"),
pt.bg=my.colors, pch=c(21,22,23), bty="n", cex=0.8, pt.cex=1)
dev.off()

##################
#Study 2 Results
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##################
agilent <- read.delim("/Users/russell/Desktop/USU Student Materials/Research
Summer 2014/Data/AllAnnotations\\019921_D_AA_20141001.txt"
, stringsAsFactors=F, fill=TRUE, sep=)
load("/Users/russell/Desktop/USU Student Materials/Research Summer 2014/Thesis/R
Code/pvals.study2")
load("/Users/russell/Desktop/USU Student Materials/Research Summer 2014/Thesis/R
Code/final.list.groups.oaries")

profileTable(pvals.study2, list.groups=final.list.groups.oaries)

